Hypo-osmolality and hyponatraemia

E4_HYPOOSMNAT

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E87.1 Hospital discharge: ICD-9 — 2761 Cause of death: ICD-10 — E87.1 Cause of death: ICD-9 — 2761 2 out of 7 registries used, show all original rules.	8127
4. Check minimum number of events None	8127
5. Include endpoints None	8127
6. Filter based on genotype QC (FinnGen only)	7957

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E87
Name in latin: Hyposmolalitas

NAME	E4_HYPOOSMNAT
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E871
HD_ICD_9	2761
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E871
COD_ICD_9	2761
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hypo-osmolality and hyponatraemia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	74063	47522	26119
Only index persons	63818	41374	22444
Unadjusted period prevalence (%)
Whole population	1.13	1.36	0.73
Only index persons	1.29	1.52	0.86
Median age at first event (years)
Whole population	73.12	77.26	65.64
Only index persons	73.08	77.07	65.73

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7957	4605	3352
Unadjusted period prevalence (%)	1.59	1.63	1.54
Median age at first event (years)	70.46	71.94	68.44

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8127: Matched controls
80810

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

15.5

318.4

280

186

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.4

317.7

667

1322

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.3

315.3

1376

4676

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.1

314.6

1545

5633

P15

ICPC

Chronic alcohol abuse

7.4

309.7

463

654

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

8.0

308.3

429

558

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.9

308.1

1758

6967

R53

ICD-10 Finland

Malaise and fatigue

3.3

307.7

2987

12036

F10.25

ICD-10 Finland

Alcohol dependence continuous use

11.8

307.7

392

345

D64.9

ICD-10 Finland

Anaemia, unspecified

3.4

307.7

1577

5310

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

307.7

4798

27673

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.6

307.7

2213

7690

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

307.7

3115

16069

E87.6

ICD-10 Finland

Hypokalaemia

35.5

307.7

936

295

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

6.0

307.7

727

1304

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.5

307.7

3564

19238

N03AX14

ATC

levetiracetam; systemic

6.8

307.7

529

823

N05AH04

ATC

quetiapine; oral

3.1

307.7

1896

7151

C03CA01

ATC

furosemide; systemic

2.9

307.7

4068

20516

C03DA01

ATC

spironolactone; oral

3.3

307.7

1664

5911

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.7

307.7

3082

14922

E87.5

ICD-10 Finland

Hyperkalaemia

36.5

307.7

464

134

G40.9

ICD-10 Finland

Epilepsy, unspecified

6.5

307.7

622

1013

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

8.4

307.7

464

581

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

8.2

307.7

1340

1902

AA1AD

NOMESCO Finland

CT of head and brain

3.7

307.7

3721

15137

R11

ICD-10 Finland

Nausea and vomiting

4.1

307.7

1280

3501

C08CA01

ATC

amlodipine; oral

2.5

307.7

4198

24113

E86

ICD-10 Finland

Volume depletion

56.2

307.7

494

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

38724.0

307.7

8066

275

N06AX11

ATC

mirtazapine; oral

2.5

307.7

3473

18445

R56.8

ICD-10 Finland

Other and unspecified convulsions

7.4

307.7

978

1473

H02AB09

ATC

hydrocortisone; systemic

8.3

307.7

442

555

N05BA04

ATC

oxazepam; oral

2.6

307.7

2854

13948

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.0

307.7

2881

9836

N03AG01

ATC

valproic acid; systemic, rectal

4.7

307.7

851

1951

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.8

307.7

827

1865

N07BB01

ATC

disulfiram; oral

5.9

307.5

578

1034

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

14.6

295.7

268

188

C07AB07

ATC

bisoprolol; oral

2.3

294.7

4888

31604

N03AF02

ATC

oxcarbazepine; oral

6.1

292.0

530

916

I10

ICD-10 Finland

Essential (primary) hypertension

2.5

289.9

5884

41404

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.1

286.5

1452

5369

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.8

284.7

1805

7534

N05CF01

ATC

zopiclone; oral

2.3

284.3

3499

19857

I50.9

ICD-10 Finland

Heart failure, unspecified

2.7

282.6

1950

8495

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

18.5

280.8

225

124

F10.24

ICD-10 Finland

Alcohol depence active use

11.3

278.9

297

271

F10.20

ICD-10 Finland

Alcohol dependence currently independent

8.7

277.2

358

425

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

12.2

276.7

279

234

A28

ICPC

Limited function/disability NOS

2.5

276.3

2225

10434

N05AH03

ATC

olanzapine; systemic

4.3

271.9

754

1874

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.7

268.4

521

959

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

9.9

262.2

306

318

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

14.3

258.9

237

169

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.2

258.0

1173

4057

A06AD11

ATC

lactulose; oral

2.6

256.2

1940

8795

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.6

255.2

1858

8264

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.8

253.8

1476

5857

E22.2

ICD-10 Finland

Syndrome of inappropriate secretion of antidiuretic hormone

83.4

248.0

132

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

241.9

1835

8301

N05BA01

ATC

diazepam; systemic, rectal

2.7

240.7

1516

6257

R63.1

ICD-10 Finland

Polydipsia

46.0

238.8

141

SPAT1254

SPAT

Administration of medicine

2.5

233.7

1773

8006

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

6.8

231.0

372

568

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.5

229.5

856

2610

A02BC02

ATC

pantoprazole; systemic

2.3

229.4

5946

44004

WX892

NOMESCO Finland

Monitored bed care

3.4

229.2

911

2893

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

81.4

226.6

121

R41.0

ICD-10 Finland

Disorientation, unspecified

4.6

222.2

556

1271

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

220.1

2107

10530

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.9

219.7

349

525

JN3AD

NOMESCO Finland

Abdominal CT examination

2.8

216.8

1237

4830

L28

ICPC

Limited function/disability (L)

2.3

215.6

2044

10161

N05AA02

ATC

levomepromazine; systemic

4.5

215.5

552

1285

A04

ICPC

Weakness/tiredness general

2.5

211.1

1583

7076

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

209.7

1835

8796

N02AA05

ATC

oxycodone; systemic

2.3

209.4

2056

10357

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

7.9

208.9

290

375

F05.9

ICD-10 Finland

Delirium, unspecified

5.6

207.4

408

758

F10.09

ICD-10 Finland

Alcohol intoxication UNS

7.4

207.1

306

425

R33

ICD-10 Finland

Retention of urine

3.0

205.2

988

3509

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.0

204.6

371

638

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

194.1

3520

22287

C08CA13

ATC

lercanidipine; oral

2.4

192.4

1640

7740

N30.0

ICD-10 Finland

Acute cystitis

2.3

190.4

1725

8356

ZXD05

NOMESCO Finland

Urgent procedure

2.1

190.3

2640

15155

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

9.1

188.1

232

259

N05AX08

ATC

risperidone; systemic

2.8

187.7

1075

4188

R55

ICD-10 Finland

Syncope and collapse

2.6

187.4

1280

5447

N05CD07

ATC

temazepam; oral

2.4

187.1

1472

6693

N06AB04

ATC

citalopram; systemic

2.2

185.5

2019

10539

TPH07

NOMESCO Finland

Cathetrisation of artery

2.7

183.1

1173

4834

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.4

180.4

1543

7273

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

11.4

173.4

182

162

R06.0

ICD-10 Finland

Dyspnoea

2.0

173.2

2511

14552

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.2

172.9

743

2460

N05AF03

ATC

chlorprothixene; systemic

5.4

169.3

342

650

N05BA06

ATC

lorazepam; systemic, sublingual

3.3

169.2

701

2270

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

11.0

167.5

180

166

R42

ICD-10 Finland

Dizziness and giddiness

2.0

166.0

2296

13046

C02AC05

ATC

moxonidine; oral

3.6

165.7

579

1682

N03AX16

ATC

[U] pregabalin

2.1

165.2

2157

11997

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

7.1

164.9

252

363

P16

ICPC

Acute alcohol abuse

7.8

164.7

231

302

K70.1

ICD-10 Finland

Alcoholic hepatitis

14.9

164.6

147

100

N03AF01

ATC

carbamazepine; oral, rectal

3.4

162.9

638

1994

E83.51

ICD-10 Finland

Hypocalcemia

63.9

160.5

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

8.3

158.2

210

257

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

156.3

2931

18417

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

14.2

155.1

142

101

N03AX09

ATC

lamotrigine; oral

4.2

154.3

423

1034

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

153.0

2095

11807

B01AC04

ATC

clopidogrel; oral

2.3

152.5

1456

7143

SPAT1262

SPAT

Handing over of treatment supplies

2.2

151.4

1669

8671

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.8

151.4

863

3336

N06AX16

ATC

venlafaxine; oral

2.5

149.9

1122

4950

N03AX18

ATC

lacosamide; systemic

12.2

149.8

150

124

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.9

148.9

274

477

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.5

148.4

1081

4709

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.1

147.4

652

2190

TKC20

NOMESCO Finland

Catheterisation of bladder

2.8

147.1

798

3004

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.1

147.0

643

2146

G72.8

ICD-10 Finland

Other specified myopathies

5.8

146.4

272

478

SPAT1263

SPAT

Sampling

1.8

144.9

3571

24295

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

143.6

2039

11602

A10AB05

ATC

insulin aspart; parenteral

2.9

143.2

729

2650

SPAT1301

SPAT

No procedures

1.9

143.1

2904

18591

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

142.5

1521

7784

A10AE04

ATC

insulin glargine; parenteral

2.6

141.5

893

3629

205

Kela drug reimbursment

Chronic hypertension

1.9

141.2

2745

17321

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.7

141.0

849

3370

N02BE01

ATC

paracetamol; systemic, rectal

2.5

140.3

7269

62498

S06.0

ICD-10 Finland

Concussion

2.4

140.2

1059

4683

K59.09

ICD-10 Finland

Constipation, unspecified

2.8

139.4

759

2860

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

27.3

139.0

J01MA02

ATC

ciprofloxacin; systemic

1.8

135.5

3426

23345

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.6

135.2

467

1343

I50.0

ICD-10 Finland

Congestive heart failure

2.5

135.1

938

3986

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.3

134.4

536

1690

J01MA12

ATC

levofloxacin; systemic

2.0

133.3

1743

9598

N05BA02

ATC

chlordiazepoxide; systemic

4.5

133.2

330

745

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.0

132.5

620

2148

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.4

132.1

341

795

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.3

132.1

523

1641

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

173.2

130.5

137

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

130.0

2129

12649

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

129.6

869

3630

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

7.3

127.9

189

262

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

127.9

1977

11514

C09AA05

ATC

ramipril; oral

1.9

127.7

2346

14449

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

127.5

1620

8813

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.1

126.9

564

1896

H02AB06

ATC

prednisolone; systemic

1.7

126.6

3969

28585

J01DB01

ATC

cefalexin; oral

2.0

126.6

6514

54266

JN4AD

NOMESCO Finland

Body CT examination

2.3

126.5

1043

4782

N06AB10

ATC

escitalopram; oral

2.1

126.3

1493

7908

R60.0

ICD-10 Finland

Localized oedema

2.2

126.2

1267

6303

N02AX02

ATC

tramadol; systemic, rectal

1.7

126.0

3603

25275

E0000UV, ,

ATC

1.8

125.8

3384

23327

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

125.6

997

4496

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.6

124.5

781

3156

SPAT1229

SPAT

Assessment of need for aid

2.4

124.5

936

4119

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

123.5

2388

14916

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.3

123.3

1030

4747

A41.9

ICD-10 Finland

Sepsis, unspecified

3.4

123.1

458

1381

WX882

NOMESCO Finland

High dependency care

4.1

122.2

342

848

127

Kela drug reimbursment

Transplant complication

7.0

119.9

184

266

SPAT1216

SPAT

Assessment of functional ability

2.0

119.5

1683

9469

UJF32

NOMESCO Finland

Coloscopy

1.8

118.8

2366

14879

Z72.1

ICD-10 Finland

Alcohol use

7.5

117.6

169

227

N05AX12

ATC

aripiprazole; systemic

4.4

116.9

300

696

N06AX21

ATC

duloxetine; oral

2.3

116.6

990

4588

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

116.6

958

4378

SPAT1234

SPAT

Support of social functional capacity

2.7

116.0

671

2601

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.6

116.0

742

3024

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.9

116.0

263

552

N30.9

ICD-10 Finland

Cystitis, unspecified

2.6

114.9

710

2844

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

114.3

2255

14110

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

114.0

1620

9126

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

113.8

780

3284

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

113.5

1851

10911

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

14.1

113.5

104

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.7

113.3

662

2578

R03BB04

ATC

tiotropium bromide; inhalant

2.3

112.8

1013

4803

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.5

111.8

221

411

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.3

111.7

450

1425

C10AA01

ATC

simvastatin; oral

1.7

111.3

3588

25728

S97

ICPC

Chronic ulcer skin

2.6

110.9

673

2670

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.5

110.5

404

1204

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

110.1

2470

16018

C07AB02

ATC

metoprolol; systemic

1.8

110.1

1998

12165

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.3

110.1

896

4073

T89

ICPC

Diabetes insulin dependent

3.9

109.7

337

893

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

7.1

109.4

166

237

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.3

108.8

222

425

N05AH02

ATC

clozapine; systemic

6.2

108.7

189

311

C07AA05

ATC

propranolol; systemic

1.9

108.7

1570

8876

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

9.9

108.6

125

127

Z94.0

ICD-10 Finland

Kidney transplant status

8.1

108.3

146

182

S01.0

ICD-10 Finland

Open wound of scalp

2.4

107.7

818

3605

R50.9

ICD-10 Finland

Fever, unspecified

2.1

107.7

1271

6692

W19

ICD-10 Finland

Unspecified fall

2.2

107.7

981

4673

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

107.1

1974

12061

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

106.5

1395

7622

N03AX12

ATC

[U] gabapentin; oral

2.0

106.5

1417

7785

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

105.2

1570

8964

K70.4

ICD-10 Finland

Alcoholic hepatic failure

14.5

105.0

N06AB06

ATC

sertraline; oral

2.3

104.8

872

3997

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

18.3

104.8

WX730

NOMESCO Finland

Conventional respirator

5.3

104.7

215

414

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

104.6

1385

7592

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.4

104.4

777

3392

E87.2

ICD-10 Finland

Acidosis

349.8

104.2

105

N04AA02

ATC

biperiden; systemic

4.7

103.9

243

523

SPAT1167

SPAT

Insertion of urinary catheter

3.3

103.5

418

1325

E23.00

ICD-10 Finland

Panhypopituitarism

14.3

103.3

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.4

103.3

783

3446

L04AD02

ATC

tacrolimus; systemic

9.3

103.2

125

136

V03AA01, ,

ATC

5.5

103.0

200

366

ZX120

NOMESCO Finland

Intravenous

2.3

102.1

854

3922

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

101.9

2328

15110

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

19.3

101.0

C03AA03

ATC

hydrochlorothiazide; oral

2.2

100.8

976

4758

WX872

NOMESCO Finland

Intensive care

3.0

100.3

475

1652

R51.80

ICD-10 Finland

Headache

2.1

100.1

1119

5764

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.9

99.7

225

470

A46

ICD-10 Finland

Erysipelas

1.9

98.8

1373

7637

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

98.5

2760

18902

C01DA14

ATC

isosorbide mononitrate; oral

1.9

98.1

1506

8657

P29

ICPC

Psychological sympt/compl other

3.0

98.1

463

1607

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.2

97.2

933

4530

G40

ICD-10 Finland

Epilepsy

7.6

95.8

136

180

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.7

95.8

308

842

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

95.7

913

4421

L04AA06

ATC

mycophenolic acid; systemic

5.3

95.5

196

377

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

95.1

2469

16537

K92.1

ICD-10 Finland

Melaena

2.6

94.9

579

2299

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.2

94.8

262

643

N17.8

ICD-10 Finland

Other acute renal failure

6.2

94.5

162

263

TK800

NOMESCO Finland

Hemodialysis

4.7

94.2

220

473

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.5

93.5

327

946

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.9

93.2

469

1685

K92.0

ICD-10 Finland

Haematemesis

3.7

93.2

305

844

183

Kela drug reimbursment

Lamotrigin and topiramate

8.4

93.0

122

147

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

92.5

2246

14754

SPAT1240

SPAT

Therapeutic discussion

2.4

92.0

705

3112

WW500

NOMESCO Finland

Blood transfusion

3.0

91.8

426

1464

J01EA01

ATC

trimethoprim; systemic

1.7

91.2

2333

15530

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

8.0

90.9

123

154

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

90.8

1608

9640

A02BC05

ATC

esomeprazole; systemic

1.6

90.8

3234

23411

Z51.5

ICD-10 Finland

Palliative care

2.2

90.5

853

4105

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.4

90.3

337

1016

N05BE01

ATC

buspirone; oral

3.6

90.1

300

840

I95.1

ICD-10 Finland

Orthostatic hypotension

2.9

89.6

448

1604

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

89.4

517

1997

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.3

89.4

728

3298

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.7

89.3

208

446

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

14.3

88.9

N05AF05

ATC

zuclopenthixol; systemic

6.9

88.9

138

202

V03AE01

ATC

polystyrene sulfonate; oral

5.9

88.0

160

275

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

88.0

3037

21769

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

87.7

533

2111

SPAT1260

SPAT

Consultation of another employee

1.8

87.5

1536

9174

A29

ICPC

General symptom/complaint other

2.0

87.3

1163

6356

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.3

86.9

229

542

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.6

86.8

526

2080

T90

ICPC

Diabetes non-insulin dependent

1.7

86.3

1915

12235

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

86.1

3057

22035

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.4

85.8

663

2935

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

85.7

1537

9233

A11CC03

ATC

alfacalcidol; systemic

4.3

85.4

224

528

Z2446

NOMESCO Finland

Social worker

2.5

85.0

552

2256

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.1

84.9

913

4618

P72

ICPC

Schizophrenia

4.7

84.7

199

430

WZC30

NOMESCO Finland

Teaching

1.9

84.6

1276

7261

H02AA02

ATC

fludrocortisone; oral

6.3

84.5

143

229

G41.9

ICD-10 Finland

Status epilepticus, unspecified

8.4

83.8

109

130

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

82.9

559

2325

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

82.7

1145

6331

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

9.0

82.5

102

114

SPAT1265

SPAT

Breathalyser

7.5

82.3

118

158

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

81.8

857

4291

A02BC01

ATC

omeprazole; systemic

1.6

81.3

2318

15781

A10AC01

ATC

insulin (human); parenteral

2.3

81.2

658

2970

N05AB03

ATC

perphenazine; systemic, rectal

3.1

81.1

344

1121

N06AX03

ATC

mianserin; oral

2.6

80.7

478

1867

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

80.6

2138

14283

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.7

80.5

458

1753

R02

ICPC

Shortness of breath/dyspnoea

1.9

80.2

1108

6118

M54.5

ICD-10 Finland

Low back pain

1.6

79.5

2596

18250

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.4

78.7

199

456

C08CA02

ATC

felodipine; oral

2.0

78.5

961

5088

R18

ICD-10 Finland

Ascites

3.8

78.5

245

656

J01FF01

ATC

clindamycin; systemic

1.7

78.4

2067

13773

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

78.2

933

4894

C09AA02

ATC

enalapril; systemic

1.7

78.1

1774

11362

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.4

78.0

548

2322

105

Kela drug reimbursment

Adrenal cortical hypofunction

18.0

78.0

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

14.6

77.9

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.7

77.8

456

1772

K70.0

ICD-10 Finland

Alcoholic fatty liver

6.9

77.6

120

175

N06AA09

ATC

amitriptyline; systemic

2.0

77.5

884

4562

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.6

77.3

490

1978

A01

ICPC

Pain general/multiple sites

2.1

76.9

814

4086

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

76.8

1456

8860

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

76.6

2433

16958

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.9

76.6

234

617

A10AE05

ATC

insulin detemir; parenteral

2.7

76.3

441

1701

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

76.2

396

1446

U05

ICPC

Urination problems other

2.5

75.6

522

2193

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

75.4

1337

7972

Z3231

NOMESCO Finland

Registered nurse

1.6

75.2

2119

14333

C09CA01

ATC

losartan; oral

1.6

74.3

2217

15200

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

8.5

74.1

114

N05AD01

ATC

haloperidol; systemic

2.9

73.9

361

1275

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

73.5

1927

12788

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

8.1

73.2

121

P99

ICPC

Psychological disorders other

3.8

73.2

227

605

AN1

Coronary angiography

2.0

72.8

888

4689

P03

ICPC

Feeling depressed

2.3

72.6

559

2465

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.9

72.4

344

1196

B01AB05

ATC

enoxaparin; parenteral

1.6

72.3

2576

18394

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.9

72.2

362

1296

137

Kela drug reimbursment

Uraemia requiring dialysis

7.5

72.2

104

140

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

72.2

1721

11136

N06AB03

ATC

fluoxetine; oral

2.0

72.1

940

5077

SPAT1310

SPAT

Counselling related to known health issue

1.6

72.1

2473

17502

J01CA08

ATC

pivmecillinam; oral

1.5

72.0

3222

24198

E23.03

ICD-10 Finland

Lack of ACTH

18.1

72.0

SPAT1255

SPAT

Intravenous administration of medicine

2.2

71.9

631

2941

2761A

ICD-9 Finland

Disorders of fluid, electrolyte and acid-base balance, Hyposmolality and/or hyponatraemia

+∞

71.8

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

5.2

71.8

148

286

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

71.7

736

3648

N05BA12

ATC

alprazolam; oral

2.0

71.7

834

4330

N19

ICD-10 Finland

Unspecified kidney failure

2.8

70.9

360

1298

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.3

70.8

582

2640

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

70.7

724

3586

ZY010

NOMESCO Finland

Hospital outpatient

2.9

70.6

355

1273

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

9.6

70.5

N06AA12

ATC

doxepin; systemic

2.4

70.5

509

2182

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

7.0

70.4

108

156

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

70.4

1399

8606

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

70.1

1814

11974

F61.0

ICD-10 Finland

Mixed personality disorders

5.3

70.0

143

274

K59.0

ICD-10 Finland

Constipation

2.3

69.9

559

2505

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.1

69.7

706

3481

A10AB04

ATC

insulin lispro; parenteral

3.6

69.6

237

673

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

69.6

3610

27915

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.9

69.5

126

216

A12AA04

ATC

calcium carbonate; oral

4.9

69.0

152

311

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

4.3

68.7

181

428

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

68.7

689

3384

101

Kela drug reimbursment

Anterior pituitary hypofunction

8.1

68.6

114

UKC02

NOMESCO Finland

Cystoscopy

1.7

68.5

1366

8407

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.2

68.4

274

863

I95.9

ICD-10 Finland

Hypotension, unspecified

4.2

68.2

187

456

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.4

68.0

251

751

N05AB01

ATC

dixyrazine; systemic

4.8

68.0

153

319

SPAT1252

SPAT

Overall medication plan or its review

2.1

67.9

680

3337

J01MA14

ATC

moxifloxacin; systemic

2.1

67.9

745

3784

H04AA01

ATC

glucagon; nasal, parenteral

4.8

67.7

154

324

B03XA02

ATC

darbepoetin alfa; parenteral

3.8

67.7

212

569

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.8

67.6

355

1303

M05BX04

ATC

denosumab; parenteral

2.1

67.4

660

3210

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

10.2

67.4

N05BA09

ATC

clobazam; oral

8.9

67.3

C10AA05

ATC

atorvastatin; oral

1.5

67.2

3095

23291

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.7

67.1

368

1381

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

67.1

4983

41367

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

66.9

652

3165

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

66.9

518

2289

N05AA01

ATC

chlorpromazine; systemic, rectal

5.0

66.8

145

293

R03AC02

ATC

salbutamol; inhalant

1.5

66.8

3924

31036

N03AE01

ATC

clonazepam; systemic

2.3

66.6

518

2293

B05DA

ATC

Isotonic solutions

8.0

66.3

113

SPAT1097

SPAT

Recording of ECG

1.7

66.1

1278

7787

N05AC02

ATC

thioridazine; oral

3.9

65.9

200

525

U08

ICPC

Urinary retention

3.5

65.7

226

646

K08.3

ICD-10 Finland

Retained dental root

2.1

65.7

656

3214

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.1

65.3

283

934

K07

ICPC

Swollen ankles/oedema

2.4

65.2

495

2168

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

6.1

65.0

113

186

F60.9

ICD-10 Finland

Personality disorder, unspecified

6.1

65.0

113

186

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.8

64.9

346

1280

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

64.8

1025

5882

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.2

64.8

268

860

K86.1

ICD-10 Finland

Other chronic pancreatitis

5.7

64.8

122

217

JN4BD

NOMESCO Finland

Extensive body CT

1.9

64.7

932

5193

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

64.6

3202

24405

R40.2

ICD-10 Finland

Coma, unspecified

5.5

64.6

125

228

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

64.5

979

5546

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

15.6

64.4

B05DB

ATC

Hypertonic solutions

8.5

64.3

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

7.9

64.1

112

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

10.0

63.2

C07AG02

ATC

carvedilol; oral

2.2

63.0

558

2607

Z49.2

ICD-10 Finland

Other dialysis

7.4

63.0

123

N18.8

ICD-10 Finland

Other chronic renal failure

3.3

62.8

237

719

ZY000

NOMESCO Finland

Hospital inpatient

5.7

62.8

117

206

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.3

62.8

511

2305

102

Kela drug reimbursment

Diabetes insipidus

15.9

62.8

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

62.8

904

5035

H03AA01

ATC

levothyroxine sodium; systemic

1.6

62.6

1807

12206

P01

ICPC

Feeling anxious/nervous/tense

2.2

62.5

582

2774

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.7

62.1

201

552

S18

ICPC

Laceration/cut

1.5

61.7

3537

27678

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

11.2

61.7

N05CF02

ATC

zolpidem; oral

1.7

61.7

1281

7949

U07

ICPC

Urine symptom/complaint other

2.1

61.6

661

3325

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

4.2

61.4

164

392

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

9.3

61.4

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

61.4

815

4418

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.5

61.4

395

1604

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

61.4

864

4775

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.3

61.3

123

232

N06AX26

ATC

vortioxetine; oral

2.3

61.3

469

2060

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

61.2

1056

6216

188

Kela drug reimbursment

Psychosis requiring demanding treatment

5.8

61.2

112

194

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

25.3

61.1

R4110

NOMESCO Finland

Physiotherapy

1.6

60.9

2020

14084

A10AB01

ATC

insulin (human); parenteral

3.0

60.5

275

932

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.7

60.3

1415

9067

SPAT1104

SPAT

Monitoring of emergency patient

2.1

60.1

598

2924

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

59.8

3268

25282

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

59.8

573

2761

B01AF02

ATC

apixaban; oral

1.7

59.7

1150

6985

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.6

59.5

142

311

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

59.3

991

5774

E000001, ,

ATC

1.6

59.2

1476

9600

D09

ICPC

Nausea

2.7

59.1

324

1215

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

59.0

1112

6711

H3603, E103,

ICD-10 Finland

7.5

58.8

112

Y94.0

ICD-10 Finland

Accident at home

3.4

58.8

219

659

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

58.8

445

1945

EBA00

NOMESCO Finland

Extraction of tooth

1.5

58.8

2437

17812

D07AC01

ATC

betamethasone; topical

1.5

58.7

2688

20051

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.9

58.4

172

442

SPAT1211

SPAT

Application of soft bandage

1.9

58.0

755

4062

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

8.9

58.0

M79.6

ICD-10 Finland

Pain in limb

1.5

57.9

2994

22869

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

57.8

504

2338

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.1

57.8

163

406

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.1

57.8

159

389

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

6.1

57.8

100

164

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

10.2

57.7

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.3

57.4

218

664

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

57.4

328

1257

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.8

57.2

104

179

A10AA01, ,

ATC

3.5

57.2

201

583

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

57.1

1474

9661

F20

ICD-10 Finland

Schizophrenia

7.3

57.1

116

K59.1

ICD-10 Finland

Functional diarrhoea

2.3

57.1

466

2104

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

6.3

57.0

153

Z71.8

ICD-10 Finland

Other specified counselling

1.5

56.9

2003

14113

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

56.9

2897

22044

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

56.8

1112

6777

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

56.8

1915

13365

XA400

NOMESCO Finland

EEG

6.9

56.6

126

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.8

56.5

177

475

F34.1

ICD-10 Finland

Dysthymia

3.0

56.4

261

894

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

6.5

56.0

140

C09CA03

ATC

valsartan; oral

1.9

55.8

801

4447

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.7

55.8

320

1228

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

5.4

55.4

109

202

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.0

55.3

250

845

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

5.4

55.3

110

206

A02BC03

ATC

lansoprazole; oral

1.5

55.2

2284

16642

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.5

55.2

349

1405

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.6

54.9

182

508

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

8.1

54.6

207

Kela drug reimbursment

Chronic arrhythmias

1.6

54.6

1425

9357

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

10.0

54.5

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

54.2

852

4866

K86.3

ICD-10 Finland

Pseudocyst of pancreas

8.3

53.6

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

53.4

802

4514

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

53.3

440

1995

SPAT1125

SPAT

Stoma care and guidance

3.2

53.3

211

660

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.2

53.3

211

660

N03AX23

ATC

brivaracetam; systemic

17.9

53.0

SPAT1307

SPAT

Psychosocial counselling and guidance

2.6

52.8

325

1291

N06AB05

ATC

paroxetine; oral

2.3

52.8

430

1939

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

52.7

982

5895

S22.3

ICD-10 Finland

Fracture of rib

2.0

52.6

576

2914

N06AX05

ATC

trazodone; oral

3.2

52.6

209

655

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

52.5

391

1696

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

52.3

622

3241

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.2

52.3

483

2292

N88

ICPC

Epilepsy

6.5

52.2

131

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.1

52.1

520

2542

D10

ICPC

Vomiting

2.6

52.1

322

1282

R06AE07

ATC

cetirizine; oral

1.4

51.8

3030

23554

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

8.6

51.6

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

51.2

1358

8937

ZXE00

NOMESCO Finland

One hour or less

1.5

51.1

2769

21205

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

51.1

1318

8615

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.3

51.1

104

199

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

51.1

2674

20347

F05.8

ICD-10 Finland

Other delirium

4.9

50.8

111

226

G40.89

ICD-10 Finland

Other epilepsy

7.9

50.7

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.5

50.5

123

274

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.0

50.4

108

216

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.5

50.4

329

1344

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.1

50.4

509

2499

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

17.8

50.4

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.0

50.2

146

372

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.2

50.2

136

329

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.4

50.2

130

I50

ICD-10 Finland

Heart failure

2.4

50.1

352

1487

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.4

49.7

181

537

SPAT1227

SPAT

Substance abuse rehabilitation

7.8

49.7

A10BA02

ATC

metformin; oral

1.5

49.6

2135

15615

R5110, ,

SPAT

2.0

49.3

565

2904

XF404

NOMESCO Finland

Ambulatory ECG

1.9

49.2

689

3789

XX3DW

NOMESCO Finland

Time consuming IT work

1.8

49.2

860

5062

N02BF02

ATC

pregabalin; oral

2.2

49.2

441

2067

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

49.0

914

5480

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.6

49.0

290

1130

I20.09

ICD-10 Finland

Unstable angina

2.2

49.0

448

2117

N05AN01

ATC

lithium; oral

3.4

48.9

181

543

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

48.9

3180

25130

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.8

48.6

243

868

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

48.5

454

2164

K85

ICPC

Elevated blood pressure

1.6

48.4

1380

9228

G04CA02

ATC

tamsulosin; oral

1.5

48.3

1735

12212

G40.10

ICD-10 Finland

Simple partial seizures

5.7

48.2

159

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

48.2

846

4986

SPAT1247

SPAT

Outpatient detoxication and monitoring

8.8

48.0

P76

ICPC

Depressive disorder

2.3

48.0

369

1623

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

5.1

47.8

100

196

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.7

47.8

272

1040

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

47.7

447

2131

SPAT1312

SPAT

General health counselling

1.5

47.4

2288

17089

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

13.7

47.3

E23.2

ICD-10 Finland

Diabetes insipidus

13.7

47.3

V03AB30, ,

ATC

5.7

47.3

155

H3600, E103,

ICD-10 Finland

6.1

47.2

135

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.8

47.2

249

916

OAB43, ,

SPAT

0.4

47.1

325

6990

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

47.0

344

1480

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

47.0

351

1524

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.5

46.9

306

1250

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

46.7

782

4542

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.8

46.7

105

219

U02

ICPC

Urinary frequency/urgency

1.6

46.5

1100

7021

K90

ICPC

Stroke/cerebrovascular accident

2.7

46.5

256

962

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

13.3

46.5

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.2

46.4

184

576

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.1

46.3

194

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.4

46.3

166

488

R52.9

ICD-10 Finland

Pain, unspecified

1.8

46.2

715

4056

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.1

46.1

453

2200

P20

ICPC

Memory disturbance

1.6

46.1

1313

8767

U04

ICPC

Incontinence urine

2.0

46.0

525

2693

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.6

45.9

269

1043

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.4

45.9

312

1299

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.5

45.7

296

1205

J96.0

ICD-10 Finland

Acute respiratory failure

3.8

45.7

143

384

N07BA03

ATC

varenicline; oral

2.5

45.5

294

1196

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

8.2

45.4

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

45.4

812

4808

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.2

45.1

381

1742

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

45.1

1536

10669

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.0

44.9

524

2709

B01AA03

ATC

warfarin; systemic

1.5

44.9

1688

11972

D11

ICPC

Diarrhoea

1.8

44.9

718

4113

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.9

44.6

211

732

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

44.6

425

2040

A02BA02

ATC

ranitidine; systemic

1.5

44.5

1567

10959

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.5

44.5

109

244

M05BA04

ATC

alendronic acid; oral

1.7

44.5

930

5746

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.6

44.4

148

415

S72.0

ICD-10 Finland

Fracture of neck of femur

2.1

44.4

455

2245

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

44.3

530

2764

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.5

44.2

298

1236

IGV01

NOMESCO Finland

Psychiatric network contact

6.6

44.2

108

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.0

44.1

191

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

44.1

471

2359

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

6.0

44.0

131

U71

ICPC

Cystitis/urinary infection other

2.0

43.9

537

2821

K56.7

ICD-10 Finland

Ileus, unspecified

3.2

43.9

178

565

WX002

NOMESCO Finland

Sedation and analgesia

1.5

43.9

1466

10134

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.5

43.8

109

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

43.7

377

1739

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

153.3

43.7

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.0

43.7

192

639

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

43.6

936

5820

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

43.6

495

2534

A10AE06

ATC

insulin degludec; parenteral

2.8

43.6

225

818

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.8

43.5

220

791

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.8

43.5

655

3682

F32

ICD-10 Finland

Depressive episode

2.3

43.5

323

1399

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

4.4

43.4

110

253

XA800

NOMESCO Finland

Neuropsychological investigation

2.6

43.4

258

1008

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

43.4

514

2671

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

43.3

566

3041

N03AB02

ATC

phenytoin; systemic

3.6

43.1

142

395

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.1

43.1

183

597

D64.8

ICD-10 Finland

Other specified anaemias

3.1

43.0

181

587

P74

ICPC

Anxiety disorder/anxiety state

2.7

43.0

233

869

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

10.9

43.0

C09CA06

ATC

candesartan; oral

1.5

43.0

1709

12246

Z00.8

ICD-10 Finland

Other general examinations

1.9

43.0

546

2906

D07AA02

ATC

hydrocortisone; topical

1.7

43.0

937

5851

X58

ICD-10 Finland

Exposure to other specified factors

1.7

42.8

922

5737

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.5

42.8

277

1127

A04AA01

ATC

ondansetron; systemic, rectal

1.9

42.7

613

3395

H02AB04

ATC

methylprednisolone; systemic

1.6

42.5

1089

7081

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.7

42.4

100

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.9

42.4

125

322

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.6

42.3

143

405

I25.2

ICD-10 Finland

Old myocardial infarction

2.0

42.3

494

2555

E83.50

ICD-10 Finland

Hypercalcemia

5.4

42.2

154

D12

ICPC

Constipation

2.3

42.2

320

1399

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.8

42.1

219

800

R95

ICPC

Chron obstructive pulmonary disease

2.5

42.0

259

1030

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.3

42.0

159

484

K02.1

ICD-10 Finland

Caries of dentine

1.4

42.0

3709

30604

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

6.2

41.9

114

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

8.7

41.9

C09DA06

ATC

candesartan and diuretics; oral

1.9

41.9

594

3276

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

41.8

528

2803

A07AA02

ATC

nystatin; oral

1.9

41.7

523

2770

S00.0

ICD-10 Finland

Superficial injury of scalp

2.8

41.7

220

809

R04.0

ICD-10 Finland

Epistaxis

1.8

41.6

631

3554

N17

ICPC

Vertigo/dizziness

1.6

41.5

978

6224

N06AX12

ATC

bupropion; oral

2.3

41.5

331

1478

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.0

41.5

120

305

R07.3

ICD-10 Finland

Other chest pain

1.8

41.5

731

4305

K29.2

ICD-10 Finland

Alcoholic gastritis

10.7

41.4

J01DA01

ATC

[U] cefalexin

1.4

41.4

4473

38084

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.9

41.3

514

2716

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.9

41.2

122

315

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.7

41.2

131

356

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.7

41.1

199

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

8.7

41.0

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.6

41.0

215

SPAT1053

SPAT

Memory test

1.5

40.6

1381

9565

M48.0

ICD-10 Finland

Spinal stenosis

1.6

40.6

1049

6827

P01AB01

ATC

metronidazole; oral, rectal

1.4

40.6

2682

21064

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

40.5

308

1347

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

15.0

40.5

A10BH05

ATC

linagliptin; oral

2.1

40.4

417

2061

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

40.4

1365

9442

SPAT1304

SPAT

Counselling and guidance related to ageing

1.7

40.4

747

4459

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.7

40.4

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

4.5

40.3

218

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.9

40.3

183

R35

ICD-10 Finland

Polyuria

1.9

40.1

535

2893

R39.1

ICD-10 Finland

Other difficulties with micturition

2.5

40.0

253

1018

F31

ICD-10 Finland

Bipolar affective disorder

4.8

40.0

188

Z3226

NOMESCO Finland

Physiotherapist

1.5

40.0

1268

8649

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.4

39.8

272

1135

ZXD35

NOMESCO Finland

Usual procedure

2.4

39.6

270

1126

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

8.9

39.5

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

39.5

333

1522

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.3

39.3

105

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.9

39.2

117

304

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.5

39.2

245

981

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

11.8

39.1

A99

ICPC

Disease/condition unspecnature/site

1.7

39.0

707

4194

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.6

38.8

129

361

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

38.8

701

4154

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

4.3

38.8

229

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.4

38.8

269

1130

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

38.8

329

1507

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.6

38.8

130

366

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

38.8

1029

6735

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.3

38.8

308

1373

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

38.7

401

1985

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

3.8

38.7

119

316

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.1

38.7

165

540

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

5.7

38.7

127

AA400

NOMESCO Finland

Electroconvulsive therapy

5.3

38.5

145

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.2

38.5

103

247

K77

ICPC

Heart failure

2.6

38.5

235

930

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

38.5

2059

15557

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019309) Folate [Moles/volume] in Red Blood Cells

2810

13891

2.55

319.23

2.1

1.7

1360.21

1176.65

nmol/l

16.11

2137

10214

(3004119) Hemoglobin [Mass/volume] in Venous blood

1190

3693

3.58

314.78

5.1

2.9

122.38

127.83

g/l

13.64

1171

3611

(3000850) Epithelial cells [#/volume] in Urine

2778

13745

2.53

314.06

3.9

2.5

5.78

5.60

e6/l

0.30

2609

12171

(3006504) Eosinophils/100 leukocytes in Blood

4563

28213

2.39

312.14

7.9

5.8

2.53

2.86

18.35

4299

25974

(3019069) Monocytes/100 leukocytes in Blood

4583

28394

2.39

312.00

8.4

6.1

9.10

8.74

10.45

4332

26194

(40760892) CBC W Ordered Manual Differential panel - Blood

4767

28296

2.63

307.65

8.5

6.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

479

600

8.37

307.65

1.5

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1900

5582

4.11

307.65

5.8

3.2

5.70

5.84

kpa

7.16

1825

5416

(3027945) Reticulocytes/100 erythrocytes in Blood

2001

7347

3.27

307.65

2.5

2.3

2.01

1.76

15.20

1746

6392

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1874

7272

3.03

307.65

3.7

4.2

247.47

245.32

u/l

0.17

1751

6821

(3026782) Osmolality of Urine

4137

12745

5.54

307.65

3.6

2.8

397.65

544.84

mosm/kgh2o

307.65

3617

10796

(3018418) pH of Serum or Plasma

3695

19432

2.63

307.65

6.0

3.5

7.40

0.17

1027

3667

(3002582) Erythrocytes [#/volume] in Urine

3560

19373

2.47

307.65

5.0

3.1

62.14

99.76

e6/l

1.29

3034

14765

(3009343) pH of Capillary blood

1251

3776

3.71

307.65

5.5

3.3

7.42

0.04

250

455

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5812

33288

3.58

307.65

12.1

5.6

1.19

1.22

mmol/l

112.83

4831

27811

(3014111) Lactate [Moles/volume] in Serum or Plasma

1781

5257

4.03

307.65

9.5

5.7

1.42

1.38

mmol/l

0.40

1727

5103

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1648

5837

3.27

307.65

2.7

2.1

0.19

0.20

g/l

11.51

1503

5407

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2444

7493

4.21

307.65

7.3

4.5

1.04

1.03

mmol/l

0.90

2296

6815

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3091

4576

10.23

307.65

2.3

2.2

416.66

369.21

nmol/l

18.74

2847

4148

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2128

9060

2.81

307.65

2.4

2.0

30.15

29.89

0.93

2060

8769

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4644

25518

2.89

307.65

6.2

3.5

57.51

69.23

ng/l

0.21

3938

18638

(3019198) Lymphocytes [#/volume] in Blood

4976

31073

2.53

307.65

7.6

5.6

1.73

1.92

e9/l

4.23

4465

27241

(3002032) Base excess in Venous blood by calculation

1898

5561

4.12

307.65

5.8

3.2

1.89

2.06

mmol/l

0.93

1604

4689

(3001604) Monocytes [#/volume] in Blood

4905

30227

2.55

307.65

7.5

5.5

0.67

0.60

e9/l

18.01

4344

25905

(3003181) Sodium [Moles/volume] in Urine

3078

647

75.53

307.65

1.6

1.1

56.38

67.16

mmol/l

7.88

2418

490

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1212

3659

3.70

307.65

5.5

3.3

2.10

1.99

mmol/l

0.38

926

2758

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1868

7164

3.07

307.65

2.1

1.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

5530

31313

3.37

307.65

18.3

16.5

1.25

1.33

inr

6.54

1950

8693

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4006

19119

3.14

307.65

3.1

2.0

315.27

220.07

u/l

3.57

3803

17673

(3027801) Oxygen [Partial pressure] in Arterial blood

2043

7183

3.44

307.65

10.4

6.0

11.58

12.20

kpa

6.35

1952

6804

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1253

3426

4.12

307.65

9.4

6.3

24.46

25.01

mmol/l

4.09

1234

3391

(3023368) Bacteria identified in Blood by Culture

4153

17924

3.67

307.65

5.6

4.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2493

9501

3.32

307.65

3.2

2.2

11.23

12.49

umol/l

13.29

2280

8692

(3023183) Ammonium ion [Moles/volume] in Plasma

784

1072

7.94

307.65

3.3

2.4

33.56

34.55

umol/l

0.46

719

950

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4285

24105

2.62

307.65

3.8

2.6

191.92

145.48

ug/l

7.07

3885

21767

(3016038) Potassium [Moles/volume] in Urine

1120

227

56.74

307.65

1.3

1.1

31.30

36.96

mmol/l

2.99

964

179

(3000991) Gas panel - Venous blood

1615

4919

3.83

307.65

11.6

6.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

5446

35624

2.58

307.65

12.6

8.6

4.70

4.15

e9/l

39.08

4881

30898

(3008295) Osmolality of Serum or Plasma

1291

427

35.55

307.65

1.4

1.3

263.99

284.51

mosm/kgh2o

56.12

1036

304

(3024561) Albumin [Mass/volume] in Serum or Plasma

5113

28315

3.15

307.65

7.1

4.3

32.95

35.07

g/l

108.46

4797

25947

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1263

3838

3.69

307.65

5.6

3.3

5.09

5.20

kpa

3.08

1208

3595

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5395

30188

3.31

307.65

11.6

5.0

1.19

1.22

mmol/l

127.10

5042

26973

(3020779) Urea [Moles/volume] in Serum or Plasma

1685

5109

3.88

307.65

9.1

5.5

9.96

10.11

mmol/l

0.32

1604

4815

(3031040) Bacteria [#/volume] in Urine by Automated count

6261

43255

2.91

307.65

8.2

4.7

1116.81

2388.93

e6/l

1.40

111

557

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2228

8183

3.35

307.65

3.2

2.2

20.69

21.82

2.78

1880

6824

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4069

19976

3.05

307.65

4.0

2.4

57.16

61.86

u/l

1.64

3804

18252

(3021960) Folate [Moles/volume] in Serum or Plasma

3087

15819

2.52

307.65

1.8

1.5

20.56

20.77

nmol/l

0.28

2701

13171

(3013115) Eosinophils [#/volume] in Blood

5011

31322

2.54

307.65

7.9

5.7

0.18

0.19

e9/l

6.47

4471

27202

(3012544) pH of Venous blood

1924

5751

4.05

307.65

5.7

3.2

7.39

0.16

(3023520) Reticulocytes [#/volume] in Blood

1598

5538

3.33

307.65

2.6

2.5

72.98

68.01

e9/l

4.91

1256

4247

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3673

16187

3.29

307.65

2.8

2.2

3.07

3.11

mg/l

0.38

3168

13677

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1436

4635

3.53

307.65

1.9

1.6

—

(3006315) Basophils [#/volume] in Blood

4925

30337

2.56

307.65

7.5

5.5

0.04

e9/l

0.56

4359

25986

(3003396) Base excess in Arterial blood by calculation

2057

7130

3.50

307.65

10.4

6.1

1.16

1.22

mmol/l

0.20

1660

5629

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1864

7163

3.06

307.65

2.2

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5704

33145

3.39

307.65

9.1

5.9

11.98

11.90

umol/l

0.11

5460

31272

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2754

10604

3.39

307.65

2.2

1.8

—

(3016502) Oxygen saturation in Arterial blood

1863

6364

3.48

307.65

10.8

6.4

95.44

95.56

0.34

1802

6105

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2043

7185

3.44

307.65

10.4

6.1

4.92

5.10

kpa

11.52

1958

6809

(3013826) Glucose [Moles/volume] in Serum or Plasma

6109

37454

3.50

307.65

9.7

4.1

7.00

6.74

mmol/l

14.76

5939

34937

(3024354) Oxygen [Partial pressure] in Venous blood

1571

4680

3.90

307.65

5.3

2.7

4.57

4.45

kpa

1.15

1509

4528

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2346

8718

3.36

307.65

3.1

2.2

2.21

2.31

g/l

11.51

2146

7934

(3026008) Bacteria identified in Urine by Culture

4152

21899

2.81

307.65

4.8

3.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3060

9586

4.49

307.65

4.6

2.9

0.77

0.82

mmol/l

69.79

2878

8834

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1668

5802

3.34

307.65

11.5

6.8

116.75

120.35

g/l

9.97

1634

5627

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3772

20413

2.56

307.65

4.0

2.9

2170.67

1494.09

ng/l

12.65

3305

17436

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

974

2680

3.97

307.02

5.9

3.5

24.07

24.25

mmol/l

0.77

942

2613

(3002030) Lymphocytes/100 leukocytes in Blood

4631

29045

2.36

303.20

8.1

5.9

23.25

27.15

94.39

4370

26855

(3022096) Basophils/100 leukocytes in Blood

4435

27323

2.35

302.49

7.8

5.8

0.61

0.67

9.91

4179

25118

(3018095) Leukocytes [#/volume] in Urine

3854

22419

2.35

299.81

5.9

3.5

114.18

122.10

e6/l

0.20

3167

15960

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1166

3704

3.49

296.58

1.7

1.4

—

(3019060) Gas panel - Arterial blood

1276

4330

3.29

291.70

7.0

4.3

—

(3018010) Neutrophils/100 leukocytes in Blood

4541

28594

2.31

289.50

7.7

5.7

61.02

57.75

53.06

4288

26418

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6651

49753

2.81

285.47

12.5

7.1

87.13

79.75

u/l

18.49

6377

46292

(3030467) Casts [#/volume] in Urine by Automated count

3261

18003

2.34

282.19

4.8

3.0

0.48

e6/l

0.07

2780

13756

(3027273) Bicarbonate [Moles/volume] in Venous blood

1016

3063

3.63

279.28

5.5

2.9

24.92

25.32

mmol/l

2.63

988

2982

(1616796) Gas panel - Central venous blood

607

1251

5.13

275.84

4.4

3.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

6086

44250

2.46

265.92

7.3

4.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1415

5385

2.95

263.60

2.5

1.7

1.88

1.48

30.70

1169

4626

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

946

2824

3.64

263.30

1.7

1.6

1.58

1.56

g/l

0.26

826

2378

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

802

2146

4.01

261.44

2.3

2.1

513.91

621.00

ug/l

0.32

757

2005

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

897

2606

3.72

259.85

2.2

1.8

2.04

2.61

ug/l

0.67

791

2242

(40767503) Oxygen content in Capillary blood by calculation

598

1295

4.88

256.03

3.3

2.3

15.33

16.21

4.86

326

615

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1164

4045

3.17

253.71

11.0

6.3

24.50

24.75

mmol/l

1.19

1121

3843

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3208

18197

2.24

253.67

4.4

3.1

41.45

34.55

u/l

3.35

3038

17035

(3015235) Bicarbonate [Moles/volume] in Capillary blood

632

1444

4.63

253.40

4.0

2.8

24.78

25.20

mmol/l

1.22

616

1409

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4330

27692

2.19

252.97

2.5

2.0

93.13

94.97

pmol/l

1.51

2378

13903

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

732

1881

4.15

251.98

1.4

1.2

—

(36304419) Bacteria [Presence] in Urine

3104

17441

2.25

250.49

4.8

3.0

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1142

3956

3.18

250.06

13.4

7.4

93.60

93.88

0.82

1133

3944

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1136

3923

3.18

250.05

13.4

7.4

0.68

0.70

0.53

1126

3900

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1138

3944

3.17

248.92

13.3

7.3

1.44

1.38

0.88

1128

3922

(3010421) pH of Blood

668

1643

4.32

243.56

5.6

3.6

7.42

0.10

591

1492

(3020630) Protein [Mass/volume] in Serum or Plasma

1379

5391

2.86

243.05

2.7

2.4

64.76

66.35

g/l

9.38

1243

4755

(3009466) Valproate [Moles/volume] in Serum or Plasma

429

722

6.18

242.27

5.5

4.4

388.41

353.48

umol/l

4.36

382

598

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4098

25972

2.15

241.00

2.8

2.1

78.06

80.22

nmol/l

4.35

3662

22601

(3028626) Oxygen [Partial pressure] in Capillary blood

581

1302

4.70

238.32

5.3

2.9

8.01

8.05

kpa

0.21

567

1269

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

911

2887

3.41

229.97

6.4

3.4

49.39

47.72

1.13

904

2853

(3042936) Bacteria identified in Isolate by Culture

1853

8650

2.46

226.64

2.6

1.9

—

(3013290) Carbon dioxide [Partial pressure] in Blood

592

1402

4.45

226.36

5.4

3.7

5.00

5.02

kpa

0.26

574

1367

(3012501) Base excess in Blood by calculation

591

1401

4.45

225.68

5.3

3.7

3.11

2.62

mmol/l

2.49

426

964

(3015377) Calcium [Moles/volume] in Serum or Plasma

3680

22789

2.11

225.21

3.9

3.3

2.33

2.36

mmol/l

36.86

3225

19555

(3027315) Oxygen [Partial pressure] in Blood

592

1413

4.41

224.06

5.3

3.8

8.44

8.45

kpa

0.03

574

1378

(3028271) Lactate [Moles/volume] in Capillary blood

484

1002

5.04

218.00

2.5

1.6

1.71

1.68

mmol/l

0.21

475

973

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

937

3151

3.21

214.10

13.0

7.7

24.23

24.48

mmol/l

1.21

906

3017

(3021901) Oxygen saturation in Capillary blood

491

1053

4.87

212.04

3.3

2.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

274

331

8.48

208.84

1.9

1.2

1.40

1.39

promille

0.02

206

256

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5196

37343

2.06

203.30

5.5

2.9

84.53

50.69

u/l

36.96

4822

33896

(3044640) Blood type and Crossmatch panel - Blood

3268

19921

2.06

202.82

3.4

2.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1022

3765

2.94

198.55

2.0

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

4524

31114

2.01

198.13

6.3

3.9

0.00

estimate

2.14

1250

6256

(3020891) Body temperature

838

2766

3.24

196.88

9.6

4.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

1586

7337

2.43

194.79

2.2

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

4498

31096

1.98

191.44

8.0

5.1

0.00

estimate

0.80

1211

5726

(3018405) Lactate [Moles/volume] in Arterial blood

748

2349

3.39

190.34

7.0

3.7

1.35

1.36

mmol/l

0.02

733

2324

(3009261) Glucose [Presence] in Urine by Test strip

4528

31494

1.97

187.94

6.4

3.9

0.00

estimate

0.19

1179

5658

(3004588) Protein electrophoresis panel - Serum or Plasma

1125

4485

2.73

187.84

2.5

2.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2338

12998

2.11

182.14

2.0

1.6

1.64

1.34

mg/l

2.09

1908

9903

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4243

29073

1.94

181.74

3.5

2.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1487

6907

2.40

179.64

5.9

3.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1289

5634

2.52

177.78

5.9

3.2

1.21

1.23

mmol/l

15.68

1172

4752

(3017181) Myelocytes/100 leukocytes in Blood

1222

5227

2.56

176.30

4.8

3.9

0.97

0.04

561

1821

(3005719) IgG [Mass/volume] in Serum or Plasma

1030

4068

2.74

174.44

3.2

2.8

10.85

10.56

g/l

0.89

942

3689

(3011985) Renin [Units/volume] in Plasma

331

599

5.69

172.85

2.1

1.3

98.02

46.57

mu/l

0.97

289

531

(3022313) Gas panel - Capillary blood

797

2793

3.04

168.13

6.3

3.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2525

14822

2.01

166.80

1.9

1.7

12130722.42

31929472.71

pmol/l

1.66

2028

11892

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1422

6676

2.36

166.57

3.8

2.6

11.00

9.20

umol/l

1.49

1227

5798

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

862

3177

2.90

166.02

13.9

8.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

382

815

4.84

165.53

2.4

1.6

89.04

89.35

0.39

373

800

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1310

5991

2.40

162.55

3.2

2.3

5.93

6.90

ug/l

1.35

1092

5079

(3029937) Albumin [Presence] in Urine by Test strip

2846

17600

1.94

160.13

6.8

4.3

0.00

estimate

2.18

1138

5557

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2175

12258

2.04

159.89

5.8

3.5

243.33

463.01

ng/l

1.42

1871

10057

(3021440) Promyelocytes/100 leukocytes in Blood

1142

4955

2.50

158.79

4.8

3.9

0.12

0.10

0.44

485

1566

(3002179) Metamyelocytes/100 leukocytes in Blood

1113

4795

2.52

157.01

4.6

3.8

0.70

0.71

0.07

502

1570

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5973

47108

1.98

155.37

5.2

3.9

15.68

15.00

pmol/l

57.62

5469

41733

(3033658) Prothrombin time (PT) actual/Normal

2539

15320

1.94

152.11

6.6

3.7

85.43

87.44

3.38

2473

14945

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1084

4681

2.50

151.86

4.7

3.1

104.99

86.82

ng/l

5.01

911

3887

(3028026) IgM [Mass/volume] in Serum or Plasma

826

3133

2.80

150.19

1.9

1.25

1.45

g/l

1.63

752

2798

(3015736) pH of Urine

3660

24921

1.84

149.55

5.5

3.6

6.15

5.83

3.13

111

1337

(3024928) Oxygen saturation in Venous blood

432

1118

4.00

145.79

3.1

2.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2514

15305

1.92

145.34

3.4

2.3

—

(3025159) Blasts/100 leukocytes in Blood

1061

4659

2.45

142.84

4.9

3.9

0.40

0.31

0.15

409

1292

(3043409) Potassium [Moles/volume] in Arterial blood

616

2060

3.14

140.17

7.8

3.8

3.85

3.88

mmol/l

0.72

610

2047

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

483

1397

3.59

138.70

5.0

3.2

1.80

1.52

mg/l

8.32

435

1261

(3000012) Reticulocyte production index

377

917

4.24

138.29

1.9

2.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

5885

46976

1.89

137.02

5.7

4.1

18.32

13.30

mm/h

74.19

5453

42735

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3527

24205

1.79

136.45

6.8

4.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

494

1475

3.48

135.05

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

600

2020

3.11

134.85

3.0

3.1

67.95

69.63

mg/l

0.03

451

1615

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

587

1959

3.13

133.90

2.9

3.0

5.19

2.40

ratio

0.43

130

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

598

2018

3.10

133.84

3.0

3.1

39.25

52.30

mg/l

1.26

447

1622

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

504

1543

3.40

132.44

1.5

1.6

—

(3021589) Normoblasts [#/volume] in Blood

3822

27063

1.76

131.02

18.8

9.2

0.00

e9/l

0.56

3292

22162

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

260

488

5.44

130.32

1.5

1.4

—

(40758558) Short blood count panel - Blood

2485

15603

1.84

127.01

9.4

6.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

474

1434

3.43

126.83

1.7

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1071

4972

2.32

126.21

1.8

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

465

1395

3.45

126.06

2.8

2.1

123.90

128.59

g/l

3.54

390

966

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1757

9883

1.98

125.57

4.4

2.8

2.70

2.74

e6/l

0.06

1074

5382

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

541

1786

3.16

125.53

2.1

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1895

10966

1.94

124.47

4.0

2.7

1.47

1.46

e6/l

0.01

1201

6410

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

392

1059

3.82

124.30

6.7

4.5

588.78

2141.00

iu/ml

0.53

150

(3007164) IgA [Mass/volume] in Serum or Plasma

1783

10119

1.96

123.98

1.7

1.4

3.02

2.53

g/l

8.76

1119

5733

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7212

62688

2.28

120.18

34.9

14.2

25.65

25.36

mg/l

0.35

6748

49798

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

663

2521

2.76

119.07

7.3

4.6

1.69

1.64

0.51

631

2346

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

655

2479

2.77

118.68

7.0

3.6

24.75

25.06

mmol/l

1.53

610

2250

(40760888) Immunoglobulin light chains.free panel - Serum

475

1525

3.23

115.32

3.0

3.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

156

199

7.93

113.47

2.6

2.2

60.09

51.60

umol/l

1.60

129

164

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1109

5459

2.18

112.55

3.9

2.4

33.06

47.68

u/l

0.99

932

4665

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

266

578

4.70

112.47

1.3

461.64

281.66

pmol/l

0.90

232

497

(3047181) Lactate [Moles/volume] in Blood

535

1875

2.97

111.62

7.8

5.4

1.33

1.32

mmol/l

0.10

477

1646

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

147

183

8.12

109.12

1.9

2.2

84.70

141.91

umol/l

1.31

101

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

314

798

4.03

108.37

1.8

2.2

32.63

32.42

0.32

309

792

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1116

5599

2.14

107.56

1.8

1.5

—

(3013512) EKG study

2960

20294

1.71

107.51

5.6

3.8

—

(3026250) Tacrolimus [Mass/volume] in Blood

134

153

8.84

106.65

39.8

31.1

7.19

7.22

ug/l

0.05

119

135

(3000570) Elastase.pancreatic [Mass/mass] in Stool

514

1819

2.93

105.26

1.5

1.4

245.48

274.39

ug/g

2.28

307

1089

(46235355) HIV 1 and 2 tests - Meaningful Use set

1223

6406

2.06

104.94

1.9

1.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

629

2491

2.64

103.88

7.4

4.6

0.85

0.89

1.45

598

2314

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

372

1094

3.50

103.78

1.7

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2092

13120

1.79

103.48

3.4

3.1

2.46

mmol/l

0.06

1832

11457

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

590

2275

2.70

102.72

2.7

2.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

372

1119

3.42

100.16

1.3

3.97

3.76

mmol/l

2.76

346

1051

(40768797) Stomach Pathology biopsy report

1490

8484

1.91

100.12

1.4

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

683

2871

2.49

99.52

2.3

1.9

—

(3009508) Creatinine [Moles/volume] in Urine

2829

19475

1.68

99.19

3.8

3.0

5.31

7.22

mmol/l

128.47

2352

15950

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

640

2613

2.56

99.17

2.2

1.7

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

405

1294

3.22

98.92

1.4

638.93

564.27

mg/l

0.46

381

1225

(40761536) Microorganisms panel - Urine sediment

1071

5470

2.09

97.89

7.1

4.0

—

(3044290) Cell count panel - Cerebral spinal fluid

346

1015

3.50

96.85

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6654

57301

1.85

96.78

6.4

4.6

1.96

2.11

mu/l

1.84

6163

51071

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

556

2144

2.69

96.66

3.3

2.7

0.33

0.35

u/ml

1.04

328

1214

(3041096) Erythrocytes [Presence] in Urine by Automated

2414

16046

1.71

95.82

6.0

3.5

—

(3019230) Fractional oxyhemoglobin in Venous blood

329

946

3.56

94.94

3.2

2.5

62.25

63.37

0.35

324

941

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

136

183

7.50

94.48

3.0

2.7

29.03

28.76

umol/l

0.08

143

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1905

11893

1.77

94.36

1.4

1.2

1.76

1.92

u/ml

0.18

514

3025

(3037522) Nuclear Ab [Titer] in Serum

1302

7227

1.94

93.87

1.4

1.3

596.28

530.57

titre

0.58

323

1582

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

358

1098

3.35

93.41

1.5

721.80

1435.52

e6/l

1.10

310

906

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

357

1098

3.34

92.73

1.4

1.5

24.29

35.31

e6/l

0.32

287

871

(3002079) Sodium [Moles/time] in 24 hour Urine

126

160

7.94

91.99

1.1

1.3

138.67

157.19

mmol/24h

1.28

126

160

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

304

853

3.64

90.99

1.6

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

409

1389

3.03

89.94

1.3

1.2

160.63

136.48

titre

0.20

108

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

290

796

3.72

89.66

4.1

2.5

30182.43

1275.90

u/ml

0.58

(3030981) Hyaline casts [#/volume] in Urine by Automated count

703

3142

2.34

89.06

3.9

2.5

0.32

0.31

e6/l

0.07

680

3067

(3020682) Albumin/Creatinine [Ratio] in Urine

2830

19905

1.63

88.79

4.4

3.5

21.03

6.89

mg/mmol

18.11

1827

11910

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

141

212

6.71

88.55

16.4

17.4

1472.62

1367.51

nmol/l

0.72

134

203

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

169

306

5.59

88.02

2.3

2.2

16.28

17.31

nmol/l

0.57

154

288

(44816559) Phosphatidylethanol [Mass/volume] in Blood

282

773

3.72

87.35

1.8

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

401

1388

2.97

85.21

1.2

837.00

903.20

titre

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

187

382

4.96

85.08

1.5

1.3

2.41

2.14

mmol/l

0.79

174

355

(3030313) Adrenal Ab [Titer] in Serum

32.38

84.87

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

135

205

6.64

84.00

11.8

13.1

760.43

791.86

nmol/l

0.28

129

192

(3028707) Methadone [Presence] in Urine by Screen method

189

397

4.82

83.21

4.0

2.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

345

1112

3.18

82.91

1.6

1.4

—

(3012516) Albumin [Mass/volume] in Urine

2682

18886

1.62

82.22

3.8

3.0

616.55

407.45

mg/l

1.16

1783

11512

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

581

2476

2.44

81.73

2.7

2.1

7.48

7.45

g/l

0.10

522

2152

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

580

2470

2.44

81.72

2.7

2.1

3.67

3.68

g/l

0.06

522

2151

(3009445) Proteinase 3 Ab [Units/volume] in Serum

587

2515

2.42

81.61

1.3

1.6

6.36

20.25

u/ml

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

580

2474

2.43

81.42

2.7

2.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2236

15110

1.65

80.62

5.8

3.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

391

1382

2.90

79.95

1.6

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1276

7384

1.85

79.81

3.4

4.0

13.14

23.80

ug/l

2.37

1079

6074

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4086

31863

1.55

79.63

2.9

2.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1080

5931

1.93

79.36

3.9

2.8

256.51

221.44

ng/l

1.55

1000

5401

(3025941) Bacteria identified in Stool by Culture

677

3131

2.25

78.82

1.5

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

313

983

3.25

78.50

1.6

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

252

688

3.73

78.49

5.8

15.1

7.56

7.20

mmol/l

0.66

217

554

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

670

3117

2.24

76.83

3.2

3.0

4.04

4.42

pmol/l

14.05

579

2703

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

253

705

3.65

76.46

1.7

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2331

16138

1.61

75.21

3.3

2.5

2857.07

5327.74

umol/l

2.92

1957

13702

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

541

2319

2.41

74.99

2.7

2.1

3.03

2.99

g/l

0.32

481

2000

(3000494) Fungus identified in Specimen by Culture

1219

7085

1.84

74.77

1.6

1.4

—

(3037756) Immunofixation for Serum or Plasma

375

1344

2.86

74.70

1.5

1.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

128

211

6.11

73.51

2.5

1.9

1470.86

2940.46

e6/l

0.27

153

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

288

905

3.24

72.14

1.6

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

369

1342

2.82

71.50

1.5

1.4

—

(3019977) pH of Arterial blood

153

306

5.05

71.36

3.3

2.4

7.42

0.11

133

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

532

2328

2.36

70.31

2.6

2.1

10.13

10.39

g/l

0.48

468

1991

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

278

872

3.25

69.84

1.6

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

7290

66183

1.92

69.17

46.4

16.3

134.73

139.72

mmol/l

307.65

7166

64210

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

206

534

3.91

69.10

1.6

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

290

949

3.11

67.86

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

290

949

3.11

67.86

1.6

—

(3037121) Protein [Mass/volume] in Urine

500

2177

2.37

66.77

3.9

2.8

0.34

0.30

g/l

0.37

253

785

(3042733) HLA Ab [Presence] in Serum

104

8.40

66.76

5.0

4.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

7291

66341

1.90

66.54

45.2

16.4

4.03

3.98

mmol/l

38.72

7161

64243

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

483

2099

2.37

64.75

2.7

2.2

0.94

1.14

g/l

0.33

406

1739

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

111

183

6.10

63.76

2.4

1.7

8938.68

18131.28

e6/l

0.43

112

(40761535) Cells panel - Urine sediment

1034

6006

1.82

62.75

5.3

3.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

381

1512

2.58

62.11

1.8

1.5

0.22

0.23

g/l

2.21

359

1426

(3003434) Protein [Mass/volume] in Pleural fluid

280

946

3.01

61.99

1.6

1.4

30.90

32.17

g/l

0.79

252

841

(3026692) Albumin [Mass/volume] in Peritoneal fluid

148

6.65

61.32

1.7

1.5

11.52

14.07

g/l

1.54

112

(3004809) Band form neutrophils/100 leukocytes in Blood

302

1072

2.87

61.17

3.5

3.6

1.47

1.43

0.06

275

940

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

11.03

61.03

4.5

4.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

386

1562

2.53

60.41

1.8

1.5

1.11

1.17

g/l

3.90

367

1477

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

287

998

2.93

60.35

4.3

2.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

449

1952

2.36

60.07

1.7

1.6

255.00

298.98

titre

0.12

(3020876) Protein [Mass/time] in 24 hour Urine

203

578

3.56

59.41

2.3

1.46

1.16

g/24h

0.63

108

255

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

269

912

3.00

59.18

2.0

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

130

266

4.92

59.08

2.3

2.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

120

232

5.21

58.20

1.2

53.71

65.00

0.46

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

131

274

4.82

58.01

1.2

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

375

1530

2.51

57.66

2.8

2.4

3.65

3.55

g/l

0.47

352

1448

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

158

387

4.12

57.31

1.1

1.2

—

(3019150) Specific gravity of Urine by Refractometry

2008

14155

1.55

56.96

6.7

4.5

1.01

1.02

kg/l

14.42

276

2155

(3036489) Thrombin time

439

1936

2.33

56.80

2.3

2.0

21.29

21.69

0.48

405

1697

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

229

728

3.19

56.26

1.2

1.3

0.66

2.80

nmol/l

0.69

214

697

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

244

806

3.07

56.18

6.0

6.2

12.61

11.86

mg/l

1.46

227

729

(3021879) Hepatitis B virus core Ab [Presence] in Serum

630

3219

2.03

56.10

1.5

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

236

767

3.12

55.87

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

159

401

4.00

55.44

2.3

2.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

265

925

2.91

55.34

2.0

1.3

25.21

16.28

u/ml

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

227

728

3.16

54.96

1.2

1.3

0.23

0.27

nmol/l

0.26

(3033799) Differential panel - Peritoneal fluid

103

183

5.66

54.80

2.1

1.8

—

(3042631) Mycobacterium sp identified in Specimen

269

953

2.87

54.67

2.6

2.8

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

319

1237

2.63

54.47

4.4

3.6

59.91

57.80

1.70

319

1237

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

251

858

2.97

54.43

1.6

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

210

648

3.28

54.19

1.3

—

nmol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

212

660

3.25

53.92

1.2

1.3

—

(3044007) Cell count panel - Peritoneal fluid

166

5.87

53.67

2.5

1.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

125

269

4.68

53.51

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

236

788

3.04

53.34

1.6

1.2

270.84

289.17

u/ml

0.42

158

463

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

431

1941

2.28

53.04

2.5

2.0

35.99

37.35

g/l

4.07

371

1612

(3036180) Methadone [Presence] in Urine

121

6.80

52.46

3.2

3.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

246

849

2.94

52.44

2.1

1.8

26.45

24.03

ug/l

0.20

237

827

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

145

357

4.09

52.25

1.9

1.7

—

(3036782) Glucose [Moles/volume] in Pleural fluid

196

593

3.34

52.21

1.4

1.3

6.73

6.24

mmol/l

1.41

183

538

(3039000) Anion gap in Blood

331

1337

2.52

51.96

10.0

6.3

11.67

11.18

mmol/l

1.48

307

1178

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

239

816

2.97

51.94

2.0

1.3

112.33

119.24

u/ml

0.38

184

(3018572) Chloride [Moles/volume] in Blood

331

1338

2.52

51.87

10.0

6.3

98.62

105.22

mmol/l

36.66

307

1179

(3011288) Drugs identified in Urine by Screen method

195

591

3.34

51.80

4.5

3.0

—

(3011648) Oxygen content in Venous blood

152

390

3.93

51.77

2.9

2.6

10.71

10.72

0.01

152

390

(3017569) Oxygen content in Arterial blood

129

293

4.43

51.65

2.3

2.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

216

702

3.12

51.14

3.6

2.2

—

(40768446) Kidney Pathology biopsy report

147

6.08

51.06

2.1

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

179

519

3.48

50.98

1.7

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

105

203

5.20

50.96

32.6

25.0

107.78

111.68

ug/l

0.26

172

(3021387) Prolactin [Units/volume] in Serum or Plasma

271

1001

2.75

50.92

2.4

1.7

400.74

300.70

mu/l

2.67

251

920

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

401

1784

2.30

50.77

2.6

2.0

0.05

0.04

g/l

0.13

372

1595

(3019225) pH of Specimen

1151

7304

1.66

50.09

7.1

3.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

307

1225

2.55

49.43

1.5

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

142

359

3.99

49.37

3.5

2.0

24.13

41.08

umol/l

0.62

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

199

633

3.18

48.87

1.5

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

156

425

3.70

48.79

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

340

1443

2.40

47.93

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

340

1443

2.40

47.93

1.5

1.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

140

6.02

47.77

4.1

2.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

140

6.02

47.77

4.1

2.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

875

5219

1.75

47.75

4.1

2.5

56.87

63.06

ml/min/173m2

3.90

412

2064

(3023199) Leukocytes [#/volume] in Pleural fluid

238

854

2.82

47.25

1.6

1.5

5509.34

2398.17

e6/l

0.66

196

623

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

159

5.62

47.10

3.2

2.2

128.39

139.59

nmol/l

0.49

138

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

151

415

3.67

46.63

1.4

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

255

956

2.71

46.56

1.2

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

131

6.12

46.31

1.1

—

(3023419) Bacteria identified in Sputum by Culture

261

993

2.67

46.30

2.2

2.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

196

639

3.10

46.18

1.7

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

196

639

3.10

46.18

1.7

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

106

6.81

46.17

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

194

633

3.10

45.65

1.3

598.88

399.92

u/l

0.58

184

597

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

174

533

3.30

45.47

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

174

533

3.30

45.47

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

174

533

3.30

45.47

1.5

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

292

1190

2.49

44.97

1.6

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

369

1679

2.24

44.24

2.7

2.1

0.00

g/l

0.38

342

1495

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

364

1647

2.25

44.23

2.7

2.1

0.00

g/l

-0.00

340

1489

(3016879) Cocaine [Presence] in Urine

230

841

2.77

44.08

3.5

2.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

131

5.97

44.03

1.4

21.43

28.08

g/l

2.18

104

(3052851) Hemolysis interference index of Serum or Plasma

400

1888

2.16

43.79

4.2

3.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

171

5.22

43.53

1.3

1.4

16.44

16.03

pmol/l

0.25

136

(40768806) Pleura Pathology biopsy report

210

741

2.87

43.02

1.6

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

118

6.20

42.82

1.1

—

(4035726) Immunohistochemistry procedure

933

5836

1.67

42.46

1.5

1.4

—

(3024932) HLA-DR beta [Type]

126

5.96

42.33

1.0

1.2

—

(3024471) HLA-A [Type]

130

5.86

42.11

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

182

602

3.05

41.85

2.0

1.9

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

219

807

2.75

41.36

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

139

392

3.57

41.35

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

224

837

2.71

41.18

1.4

1.6

0.62

0.82

g/l

1.86

151

622

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

240

932

2.61

40.87

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

137

386

3.57

40.81

1.7

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

136

383

3.57

40.55

1.7

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

235

908

2.62

40.43

3.7

2.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

214

790

2.74

40.28

1.6

1.5

64041.28

52662.70

e6/l

0.22

148

473

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

186

640

2.93

39.91

1.2

57.72

60.58

u/l

0.29

174

564

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

213

789

2.73

39.84

1.5

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

336

1537

2.22

39.75

2.5

2.2

87.06

90.09

1.30

322

1482

(3048689) Calprotectin [Mass/mass] in Stool

990

6385

1.62

39.73

2.3

2.1

226.21

146.53

ug/g

4.36

768

4934

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

177

594

3.01

39.71

1.6

1.8

—

(3012441) Differential panel - Pleural fluid

201

726

2.80

39.45

1.6

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

109

268

4.09

39.42

1.9

1.5

—

(40761511) CBC panel - Blood by Automated count

7010

64780

1.55

39.38

32.9

13.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

217

818

2.68

39.23

1.5

1.4

—

(3044889) 12 lead EKG panel

5156

45102

1.37

39.14

5.4

3.9

—

(3027008) Opiates [Presence] in Urine

233

915

2.58

38.79

3.7

1.9

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

213

800

2.69

38.78

1.5

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

144

434

3.34

38.67

1.7

1.4

—

(3028300) Cannabinoids [Presence] in Urine

233

918

2.57

38.54

4.0

2.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7181

66802

1.59

38.30

18.1

10.2

25.31

25.20

u/l

0.11

6997

63650

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6496

59249

1.45

37.51

32.6

13.3

76.28

75.93

ml/min/173m2

0.55

5797

48795

(3022493) Free Hemoglobin [Mass/volume] in Plasma

222

4.29

36.77

4.1

3.3

69.93

68.03

mg/l

0.08

144

(3027944) Amphetamines [Presence] in Urine

225

895

2.54

36.49

3.6

2.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6421

58538

1.43

36.27

7.5

5.7

41.66

39.91

mmol/mol

29.70

5876

52818

(3004451) EKG impression Narrative

107

276

3.89

36.27

1.4

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

207

793

2.64

36.26

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

207

793

2.64

36.26

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

207

795

2.63

36.08

1.5

1.4

—

(3035880) pH of Pleural fluid

123

352

3.51

35.83

1.3

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

306

1413

2.20

35.37

2.6

2.5

218.93

197.16

2.76

290

1340

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

102

261

3.92

34.97

1.4

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

186

689

2.72

34.82

3.4

3.8

60.64

56.46

1.73

161

583

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

624

3694

1.74

34.56

2.6

2.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

271

1205

2.28

34.33

1.7

1.6

3.65

4.29

iu/l

0.60

358

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

168

595

2.85

34.25

2.8

2.7

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

203

796

2.58

33.94

2.3

2.6

73.99

842.54

u/ml

1.28

195

790

(3027456) Digoxin [Moles/volume] in Serum or Plasma

347

1715

2.06

33.63

3.7

3.2

0.83

0.81

nmol/l

0.22

265

1333

(3009214) Lutropin [Units/volume] in Serum or Plasma

233

979

2.41

33.61

1.5

1.4

12.65

10.91

u/l

0.80

186

788

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

148

495

3.01

33.45

1.2

1.3

10.44

12.33

u/l

0.84

132

452

(3045788) Cell count panel - Pleural fluid

177

653

2.73

33.41

1.7

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

207

826

2.53

33.38

1.2

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

314

1499

2.13

33.37

2.7

3.2

790.67

640.74

u/ml

0.12

285

1361

(21494755) Public health laboratory ask at order entry panel

126

3524

0.35

33.21

1.3

1.4

—

(40762365) Oxygen content in Arterial blood by calculation

6.13

33.17

3.2

2.6

14.53

14.90

ml/dl

0.40

(3042111) Morphology [Interpretation] in Bone marrow Narrative

243

1052

2.34

32.78

1.5

—

(3012565) Volume of 24 hour Urine

243

3.92

32.61

1.8

2.2

2193.70

1852.67

1.74

205

(3008757) Leukocyte morphology finding [Identifier] in Blood

186

716

2.62

32.30

3.6

4.2

—

(4062490) Immunoglobulin typing, IgG

155

543

2.87

32.26

1.4

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

131

420

3.14

31.86

1.2

1.1

—

u/ml

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

177

670

2.66

31.79

1.1

1.66

1.53

g/l

2.79

155

589

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

207

4.12

31.21

3.1

2.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

159

3888

0.39

31.12

1.6

1.8

—

(3008037) Lactate [Moles/volume] in Venous blood

302

1459

2.10

31.11

4.8

3.0

1.60

1.67

mmol/l

0.34

297

1424

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

105

299

3.52

30.87

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

105

299

3.52

30.87

1.4

1.5

—

(3044927) Protein electrophoresis panel - Urine

174

663

2.64

30.86

1.2

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

254

3.75

30.66

1.4

1.3

61.24

65.21

0.50

207

(3028192) IgG subclass 2 [Mass/volume] in Serum

153

548

2.81

30.58

1.3

2.83

2.90

g/l

0.19

375

(3024139) IgG subclass 3 [Mass/volume] in Serum

153

548

2.81

30.58

1.3

0.40

0.43

g/l

0.57

376

(3027135) IgG subclass 1 [Mass/volume] in Serum

153

549

2.81

30.48

1.3

6.86

6.79

g/l

0.05

377

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

161

4.54

30.45

1.2

1.3

34.60

25.41

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

110

326

3.39

30.42

1.3

1.2

201.45

311.88

u/l

1.21

306

(3002385) Erythrocyte distribution width [Ratio]

5799

52504

1.34

30.03

38.4

16.7

15.35

15.33

0.08

5733

51320

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

107

315

3.41

29.90

2.5

2.3

—

(3003694) ABO and Rh group [Type] in Blood

2005

15619

1.37

29.90

1.4

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

6.48

29.53

3.0

3.3

38.90

40.97

umol/l

0.24

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

266

1249

2.16

29.51

1.5

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

158

590

2.70

29.18

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

333

1715

1.97

28.77

1.4

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

332

1709

1.97

28.73

1.4

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

123

406

3.04

28.50

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

152

564

2.71

28.43

1.5

1.6

30.71

25.35

u/ml

0.49

124

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

141

503

2.82

28.42

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

181

4.15

27.91

1.2

1.3

20.01

21.18

0.13

162

(3013005) Retinol [Moles/volume] in Serum or Plasma

194

4.03

27.88

2.8

1.5

2.03

1.94

umol/l

0.27

182

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

328

1699

1.96

27.87

1.4

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

127

433

2.95

27.81

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

212

3.88

27.79

1.3

4.25

2.99

0.58

172

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

407

2269

1.82

27.58

1.5

1.8

40.09

39.69

u/l

0.12

345

1964

(3023410) Appearance of Cerebral spinal fluid

132

463

2.87

27.47

1.7

1.8

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

199

3.93

26.93

1.8

1.5

6.08

5.89

nmol/l

0.02

166

(37021550) Renin [Units/volume] in Plasma --upright

113

4.95

26.01

1.5

1.2

228.94

59.28

mu/l

0.62

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

213

963

2.23

26.00

3.6

1.7

0.92

0.79

nmol/l

0.91

178

799

(3015171) Extractable nuclear Ab [Units/volume] in Serum

375

2077

1.83

25.95

1.3

1.2

1.53

1.19

u/ml

0.16

192

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

316

1657

1.93

25.91

2.0

1.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

132

480

2.76

25.71

1.4

13.00

12.78

u/l

0.14

126

454

(3005322) IgE [Units/volume] in Serum or Plasma

519

3166

1.67

25.59

1.3

460.26

233.09

u/ml

1.53

471

2888

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

132

482

2.75

25.51

1.6

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

287

1464

1.98

25.51

2.3

2.1

198.35

80.25

ug/min

2.29

162

816

(3022145) Colonoscopy Study observation

972

6849

1.47

25.31

1.4

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

144

4.38

25.18

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

112

377

2.98

25.13

2.6

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

7307

69227

1.49

25.11

50.0

21.1

36.62

40.00

116.07

6836

63876

(3029634) Reagin Ab [Titer] in Serum by VDRL

149

585

2.56

24.94

1.9

1.8

—

2.18

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

129

4.57

24.92

1.5

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

5.26

24.86

1.8

1.2

—

(3007461) Platelets [#/volume] in Blood

7307

69259

1.49

24.71

49.4

21.1

263.52

246.22

e9/l

66.57

7166

67075

(3035941) MCH [Entitic mass]

7308

69281

1.48

24.58

49.2

20.9

30.55

30.37

12.53

7206

67896

(3024731) MCV [Entitic volume]

7308

69285

1.48

24.53

49.3

21.0

91.36

91.43

0.57

7210

67900

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

309

1639

1.91

24.49

1.8

1.5

0.16

6.36

iu/ml

1.02

385

(3010813) Leukocytes [#/volume] in Blood

7308

69290

1.48

24.47

49.5

21.0

7.40

6.75

e9/l

47.70

7140

66821

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

112

383

2.93

24.45

1.2

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

7308

69292

1.48

24.44

49.5

21.0

4.10

4.44

e12/l

307.65

7147

66854

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

6.97

24.37

2.2

2.3

17.99

17.20

umol/l

0.13

(3000963) Hemoglobin [Mass/volume] in Blood

7308

69303

1.48

24.31

50.0

21.2

123.81

134.15

g/l

307.65

7207

67934

(3014148) Varicella zoster virus Ab [Titer] in Serum

122

440

2.78

24.16

1.1

—

(3045414) Leukocytes [Presence] in Urine

471

2848

1.68

24.00

2.7

1.8

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

105

351

3.00

23.87

1.1

302.12

291.80

mg/l

0.34

311

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

103

341

3.03

23.81

3.7

3.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2538

0.35

23.50

1.4

1.5

—

(3014271) Vancomycin [Susceptibility]

115

408

2.83

23.49

3.8

3.0

—

(3051651) Icteric interference index of Serum or Plasma

100

329

3.05

23.38

4.3

2.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

149

4.16

23.25

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

188

846

2.24

23.25

1.4

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

6.43

23.24

1.6

1.7

—

(3011412) CD3 cells [#/volume] in Blood

136

534

2.56

22.80

2.3

2.5

1.83

1.10

e9/l

0.52

124

483

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

224

3.49

22.74

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

155

650

2.40

22.58

3.9

2.6

—

(3045142) Bone marrow Pathology biopsy report

155

653

2.39

22.35

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

407

2416

1.71

22.21

1.1

370.00

179.16

titre

—

(3017732) Neutrophils [#/volume] in Blood

641

4270

1.53

21.81

4.3

3.0

6.50

5.11

e9/l

0.89

463

3288

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

315

2.99

21.32

1.5

2.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

316

2.98

21.21

1.2

1.1

34.41

26.14

u/l

0.51

283

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

402

2411

1.69

21.12

2.8

3.4

1026.47

1734.96

u/ml

0.45

346

2057

(3024891) Influenza virus A+B Ag [Presence] in Specimen

269

1434

1.89

21.03

1.3

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

6.09

20.90

7.0

10.1

5.74

5.58

mmol/l

0.07

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6563

61444

1.32

20.88

5.6

4.7

6.24

5.97

mmol/l

28.62

5845

54554

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

115

4.43

20.78

1.1

—

(3049717) Cytology report of Urine Cyto stain

421

2567

1.67

20.78

2.4

2.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

315

2.96

20.71

1.5

2.0

—

(3016750) Collection duration of Urine

337

2.88

20.65

2.0

2.1

517.26

490.83

min

1.28

246

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

179

830

2.17

20.60

1.8

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

107

394

2.72

20.43

2.4

1.5

82.99

84.01

umol/l

0.06

107

394

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

206

1012

2.05

20.40

1.3

35.23

39.92

u/l

0.27

173

871

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

318

2.93

20.38

1.2

1.1

96.70

87.61

u/l

0.29

284

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

252

3.18

20.19

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

310

2.94

20.08

1.3

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

310

2.94

20.08

1.3

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

110

419

2.63

19.67

1.1

1.2

126.15

139.62

titre

0.15

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

103

381

2.71

19.52

1.4

1.6

9.56

5.86

u/l

0.96

300

(3006922) Hepatitis E virus Ab [Presence] in Serum

332

2.84

19.44

1.1

—

(40768804) Tissue Pathology biopsy report

2983

25668

1.25

18.94

2.3

2.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.99

18.86

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

100

4.49

18.70

1.2

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

266

3.01

18.45

1.2

1.1

4.00

3.44

iu/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

181

881

2.07

18.41

1.2

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

116

471

2.47

18.22

1.3

1.07

1.46

nmol/l

4.50

108

421

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

298

2.86

17.85

3.4

2.9

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

121

4.05

17.80

1.2

294.00

291.99

pmol/l

0.02

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

260

1449

1.81

17.71

1.6

1.8

10.82

11.46

mg/l

0.58

230

1327

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

5.06

17.70

2.1

2.9

127.68

23.11

mg/l

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

362

2.66

17.56

1.2

104.94

90.92

u/l

0.60

302

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

131

3.89

17.56

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

351

2.68

17.53

1.1

1.2

29.55

26.03

u/l

0.29

283

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

154

3.63

17.50

1.8

1.4

3.01

3.29

umol/l

0.21

141

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.49

17.26

1.3

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

278

2.88

17.09

1.1

—

(3004775) Volume in Urine collected for unspecified duration

114

476

2.40

16.88

2.1

830.35

625.32

3.30

308

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

387

2.56

16.87

2.4

2.2

—

(3042517) Benzodiazepines panel - Urine

14.95

16.56

2.3

2.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

119

511

2.34

16.55

1.2

—

(3018133) Calcium [Moles/volume] in Urine

5.41

16.49

1.9

1.5

2.38

2.62

mmol/l

0.23

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

156

3.52

16.44

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

6.65

16.44

2.2

1.9

270.58

748.94

umol/l

0.49

(3001186) Copper [Moles/volume] in Serum or Plasma

4.35

16.42

1.6

1.1

17.03

16.79

umol/l

0.08

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

136

621

2.20

16.36

1.5

22.23

31.41

2.81

379

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

157

3.50

16.29

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

305

2.72

16.01

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

306

2.71

15.91

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

210

3.09

15.81

2.2

1.8

7041.67

13970.76

u/ml

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

205

3.12

15.79

3.4

2.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

175

3.31

15.78

1.1

1484.38

1549.95

miu/ml

0.16

175

(3043410) Blood group antigens tested for on Red Blood Cells

128

3.74

15.72

1.8

1.7

—

(3047189) Immunofixation for 24 hour Urine

260

2.85

15.54

1.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

4.13

15.38

1.4

1.3

10.90

11.19

0.02

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

319

2.64

15.21

1.1

399.46

287.42

mg/l

1.09

276

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

111

481

2.31

15.16

1.3

30.00

71.71

titre

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

180

3.22

15.09

1.4

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

376

2417

1.57

14.99

1.4

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

113

496

2.28

14.98

1.3

520.00

608.14

titre

0.09

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

5.47

14.63

2.6

2.0

47.15

57.38

0.63

(3024869) Neuronal Ab [Presence] in Serum

117

3.75

14.49

1.1

—

(3045424) Erythrocytes [Presence] in Urine

196

1069

1.84

14.39

1.9

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

161

3.29

14.29

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

256

2.77

14.24

1.6

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

256

2.77

14.24

1.6

2.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

336

2.53

14.22

1.2

50.39

40.46

mg/l

1.05

277

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

5.93

14.19

2.5

1.9

12.75

17.13

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

145

718

2.03

14.18

1.1

80.93

94.11

iu/ml

0.07

167

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

246

2.80

14.14

1.7

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

105

459

2.29

14.09

1.6

1.4

39.91

33.54

u/l

0.84

379

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1173

9310

1.30

14.02

15.5

7.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.15

13.97

1.4

1.2

2.45

2.16

mmol/l

0.07

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

259

2.74

13.94

1.6

2.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.31

13.89

1.1

—

(3036603) Volume of Urine

317

2.56

13.85

1.4

1.6

2103.16

1781.82

1.90

305

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.03

13.83

1.8

1.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

145

3.37

13.78

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

338

2164

1.58

13.74

1.1

0.85

1.70

u/ml

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

23.65

13.72

3.6

4.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

23.65

13.72

3.6

3.9

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

337

2.49

13.64

1.9

16.05

8.60

umol/l

1.33

241

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.29

13.43

1.1

1.2

—

(36660697) Celiac disease serology panel - Serum

590

4248

1.41

13.41

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

252

1516

1.67

13.19

1.3

87.60

37.03

u/ml

1.13

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

361

2.41

13.16

2.0

2.7

918.28

510.20

e6/l

0.45

304

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

13.71

13.16

3.0

2.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

279

2.62

13.11

1.3

1.16

1.20

nmol/l

0.15

217

(21494814) CD8 cells/100 lymphocytes in Specimen

229

2.79

13.06

2.4

2.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

202

2.92

13.04

1.3

3.78

3.20

mmol/l

0.44

184

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

431

2.28

13.00

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

311

2.51

12.86

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

168

908

1.86

12.75

1.7

3.78

4.93

mmol/24h

5.08

139

780

(3028679) Herpes simplex virus Ab [Presence] in Serum

205

2.88

12.71

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

429

2.26

12.71

1.7

1.5

0.23

0.27

nmol/l

0.33

313

(3051593) INR in Capillary blood by Coagulation assay

361

2.38

12.70

6.8

13.5

—

(3020393) Adenovirus Ag [Presence] in Stool

4.53

12.69

1.8

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

235

1406

1.68

12.58

1.3

3.48

4.72

u/ml

0.23

159

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

292

2.53

12.48

1.6

1.5

4.85

5.80

u/l

1.42

237

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

284

1790

1.60

12.37

1.5

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

130

653

2.00

12.28

3.6

3.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

193

2.90

12.26

2.7

1.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

227

2.73

12.14

1.2

1.3

—

(3022621) pH of Urine by Test strip

593

4348

1.38

12.10

4.5

3.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

104

3.65

12.06

1.3

3.8

—

(3000330) Specific gravity of Urine by Test strip

481

3406

1.43

12.01

5.8

3.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

4.58

11.99

1.3

1.6

—

(3017704) Immunofixation for Urine

310

2.45

11.97

1.6

—

(3013727) Leukocytes other/100 leukocytes in Blood

185

2.92

11.96

2.7

3.3

58.21

53.83

0.69

178

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

365

2.33

11.95

2.4

2.7

1221.96

634.18

e6/l

0.47

348

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

463

3260

1.44

11.92

1.2

123.42

128.72

iu/ml

0.11

160

1170

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

120

593

2.03

11.88

1.2

1.3

—

(21494434) Karyotype in Bone marrow

113

548

2.07

11.77

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

234

1424

1.65

11.76

1.3

3.62

5.37

u/ml

0.83

258

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

202

1183

1.72

11.73

1.3

1.2

3.64

7.09

u/ml

0.67

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

255

2.59

11.65

1.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

16.31

11.60

1.2

1.0

—

mmol/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.43

11.54

1.0

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

171

960

1.79

11.51

2.9

2.1

30.04

25.01

mg/l

0.50

248

(3014051) Protein [Presence] in Urine by Test strip

267

1688

1.59

11.51

3.9

2.6

—

(3032057) Clostridioides difficile [Presence] in Stool

147

3.12

11.49

1.8

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.15

11.40

2.0

2.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

348

2.33

11.40

2.0

2.8

0.20

0.23

e9/l

0.63

302

(3046861) Legionella sp Ag [Presence] in Urine

5.66

11.37

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

230

2.65

11.31

1.1

755.45

449.24

ng/l

0.40

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

134

3.20

11.20

1.1

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

192

2.81

11.20

1.1

1.3

239.68

451.16

ug/l

0.36

114

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

4.10

11.20

1.4

1.3

78.84

70.61

0.76

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

155

3.03

11.15

1.2

—

(40768443) Skin Pathology biopsy report

428

3011

1.44

11.09

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

3.96

11.08

1.5

1.2

224.53

78.12

u/l

0.44

(3041354) Potassium [Moles/volume] in Venous blood

157

875

1.80

10.86

3.5

2.3

4.15

4.07

mmol/l

1.45

157

869

(3035285) Chloride [Moles/volume] in Venous blood

157

875

1.80

10.86

3.5

2.3

99.43

105.58

mmol/l

18.78

157

869

(3004616) Nuclear Ab [Presence] in Serum

138

742

1.86

10.72

1.4

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1183

9701

1.25

10.60

1.3

44.72

37.26

iu/ml

0.74

408

3060

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

130

689

1.89

10.56

3.4

3.2

6.84

14.62

nmol/l

0.48

125

676

(3039443) Prostate specific Ag panel - Serum or Plasma

1113

0.36

10.32

1.4

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

342

2338

1.47

10.32

1.7

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.05

10.30

1.1

—

(4200892) Spirometry reversibility

610

4611

1.34

10.25

1.5

1.4

—

(3021788) Differential panel - Synovial fluid

199

1206

1.66

10.22

1.6

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

10.52

10.21

5.7

2.1

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

23.24

10.20

5.6

5.2

16.15

18.83

mmol/l

—

(3028433) Virus identified in Specimen by Culture

214

2.61

10.16

1.2

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

317

2.30

10.07

1.4

1.5

1.39

4.12

2.52

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

512

3779

1.37

10.05

2.4

16.19

24.57

au/ml

1.16

263

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

471

3435

1.39

9.95

1.2

1.3

57.96

57.12

au/ml

0.02

210

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

228

2.54

9.94

1.2

1.0

1.19

1.11

u/l

0.21

108

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.93

9.92

2.0

2.1

—

(40768441) Liver Pathology biopsy report

397

2.14

9.84

1.6

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

156

2.88

9.82

1.6

1.4

0.32

0.40

ug/l

0.90

(3000034) Microalbumin [Mass/volume] in Urine

108

552

1.96

9.80

2.5

2.7

98.69

21.09

mg/l

1.95

393

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.05

9.59

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.05

9.59

1.2

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

132

3.02

9.52

1.4

1.2

1.48

1.79

mmol/l

0.77

(3014891) Appearance of Pleural fluid

3.43

9.35

1.3

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

149

862

1.73

9.14

3.6

2.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

203

2.56

9.08

1.2

1.1

28.60

6.37

u/ml

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

203

1281

1.59

8.91

1.6

1.4

28.61

33.36

iu/l

1.10

171

1089

(44786800) Granulocytes/100 leukocytes in Body fluid

101

3.26

8.91

1.3

1.4

24.77

20.63

0.28

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

173

2.65

8.66

1.5

1.3

25.24

26.16

0.07

143

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

13.94

8.65

3.3

4.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

143

833

1.72

8.59

1.5

1.6

63.02

58.71

0.63

524

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

141

2.83

8.52

2.2

2.3

—

(40757373) Influenza virus identified in Isolate

132

2.87

8.31

1.5

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

112

1944

0.57

8.27

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

287

2.23

8.26

3.3

3.0

37.19

37.49

0.04

176

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

291

2018

1.45

8.23

1.7

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

184

2.55

8.19

1.1

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

249

1678

1.49

8.15

1.6

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

150

901

1.67

8.07

1.1

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

342

2.10

8.07

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

364

2.06

7.95

1.9

1.7

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.32

7.83

1.2

1.3

56.19

1117.81

ng/l

0.51

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.40

7.82

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

282

2.20

7.76

1.2

1.1

—

(4281824) Cell count and differential, peritoneal fluid

124

716

1.73

7.73

1.3

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6103

58317

1.16

7.72

4.5

3.9

1.25

1.26

mmol/l

0.67

5378

51730

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

235

1585

1.49

7.68

1.3

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

7.36

7.62

3.6

2.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.70

7.54

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

338

2.07

7.54

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

107

2.98

7.51

2.3

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

4.07

7.46

1.1

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.46

7.45

3.0

2.5

0.64

0.60

u/field

0.07

(3052592) Norovirus Ag [Presence] in Stool

141

2.69

7.40

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

147

2.65

7.37

1.2

1.3

96.44

141.40

nmol/l

1.43

103

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

104

2.97

7.25

2.2

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

503

1.85

7.24

1.3

1.2

75.67

73.85

u/ml

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

469

1.88

7.17

2.0

1.9

4.71

4.04

mg/l

0.63

442

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.14

7.17

1.4

1.2

52.73

54.47

0.05

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

505

1.84

7.15

1.3

1.2

26.47

43.69

u/ml

0.71

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

477

1.86

7.13

1.2

2.13

3.64

u/ml

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

196

1296

1.52

7.08

1.2

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.86

7.06

1.1

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

163

1040

1.57

6.93

1.3

1.2

53.75

44.90

u/ml

0.24

114

(4034850) Laboratory test

302

2178

1.39

6.92

15.0

10.4

—

(3017509) Phencyclidine [Presence] in Urine

6.27

6.89

1.4

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

357

1.99

6.88

1.4

1.5

14.34

13.43

umol/l

0.41

332

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

147

2.58

6.84

1.1

79.75

83.64

0.23

(1761482) Bacteria [#/volume] in Urine by Culture

261

1843

1.42

6.76

7.1

4.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

221

2.26

6.75

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.07

6.74

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

154

2.53

6.74

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

154

2.53

6.74

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

154

2.53

6.74

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

154

2.53

6.74

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

444

1.87

6.72

1.6

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

280

2.10

6.69

1.5

1.4

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

4.23

6.68

1.1

1.3

42.33

42.56

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

126

2.69

6.66

1.1

0.72

0.67

umol/24h

0.15

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

144

2.56

6.59

2.2

2.6

6.81

7.32

mmol/l

0.48

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

144

2.56

6.59

1.1

82.43

85.46

0.14

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

168

2.43

6.57

2.1

3.1

—

(3048879) Bone marrow aspiration report

213

2.25

6.44

1.3

1.8

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

6.13

6.42

6.1

6.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

356

1.94

6.25

2.0

1.9

1.45

2.50

u/field

0.81

226

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

148

2.49

6.25

1.1

1.3

117.97

112.47

0.52

133

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

204

1398

1.46

6.24

1.2

1.1

9.69

11.84

u/ml

—

128

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.88

6.23

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.43

6.21

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.37

6.07

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

112

680

1.65

5.90

2.5

2.0

3496.08

3749.87

u/l

0.04

257

(3007463) Buprenorphine [Presence] in Urine

14.92

5.88

3.4

4.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6491

62650

1.15

5.85

5.4

4.8

2.39

2.75

mmol/l

176.32

5783

56177

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.10

5.82

1.1

13.19

18.70

u/l

0.85

(3000475) Leukocytes [#/volume] in Synovial fluid

229

1628

1.41

5.77

1.9

1.6

13137.62

14509.01

e6/l

0.24

165

1189

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

115

708

1.62

5.75

1.2

3.44

3.60

u/ml

0.09

300

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

3.44

5.66

1.5

1.1

22.80

20.05

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1066

9179

1.18

5.61

1.2

11.33

13.29

u/ml

0.40

377

3364

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.68

5.58

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6329

61034

1.14

5.57

4.9

4.4

4.33

4.67

mmol/l

110.14

5654

55087

(37019676) Renin [Units/volume] in Plasma --supine

8.42

5.53

1.1

22.10

23.98

mu/l

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

8.42

5.53

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

147

972

1.51

5.42

1.2

1.3

215.18

215.26

miu/ml

0.00

385

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

193

1347

1.44

5.41

1.4

1.3

—

(3020491) Glucose [Moles/volume] in Blood

440

1.77

5.40

1.9

2.0

7.98

6.83

mmol/l

1.34

293

(3012920) Ethanol [Mass/volume] in Serum or Plasma

15.93

5.39

1.7

2.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

371

1.83

5.26

1.1

1.3

0.20

1.61

u/ml

2.56

226

(3017446) Testosterone [Moles/volume] in Serum or Plasma

489

3931

1.25

5.23

2.5

2.1

10.88

12.81

nmol/l

4.79

401

3495

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

4.98

5.21

1.1

1.4

67.94

39.00

mg/l

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

5.36

5.19

1.0

1.1

3854.00

4178.60

ng/l

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.45

5.11

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

105

653

1.61

5.09

1.3

1.2

6.10

53.09

u/ml

—

(3045462) Protein/Creatinine [Ratio] in Urine

4.43

5.01

6.1

8.3

90.46

42.13

g/mol

0.49

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.67

4.95

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1053

11931

0.86

4.93

3.0

3.1

0.80

0.78

ug/l

0.12

748

8175

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

3.32

4.83

1.9

2.3

1.08

1.19

mmol/l

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

101

2.56

4.73

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

262

3411

0.76

4.72

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

264

1.93

4.68

1.1

1.5

7.71

9.04

ug/l

0.27

236

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

4.27

4.59

1.2

1.1

1.48

4.52

u/l

—

(3023420) DNA double strand Ab [Units/volume] in Serum

541

1.62

4.51

1.8

1.4

54.13

24.74

iu/ml

—

(3044941) Cell count panel - Synovial fluid

146

1005

1.45

4.48

1.6

1.4

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.79

4.46

1.3

1.7

1.20

1.23

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.79

4.46

1.3

1.7

0.59

1.22

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.79

4.46

1.3

1.7

0.49

2.88

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.79

4.46

1.3

1.7

1.28

2.79

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.79

4.46

1.3

1.7

0.64

2.23

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.79

4.46

1.3

1.7

0.33

2.56

mg/l

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

326

1.81

4.45

1.1

1.25

11.14

nmol/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

315

2452

1.29

4.44

1.7

1.8

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.64

4.44

1.2

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

332

2609

1.28

4.35

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.62

4.34

1.3

1.7

0.32

1.75

mg/l

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

398

3201

1.25

4.30

4.3

3.7

105.68

84.60

u/ml

0.42

379

3067

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

564

1.59

4.29

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

613

1.56

4.23

2.2

2.3

2.22

2.26

u/field

0.02

195

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.94

4.23

1.4

1.7

48.67

45.33

umol/l

0.19

(3045683) HLA typing for celiac disease panel - Blood or Tissue

225

1.95

4.22

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6243

60456

1.12

4.14

4.9

4.3

1.51

1.50

mmol/l

1.82

5541

54183

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.97

4.07

1.5

3.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.52

4.07

1.5

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.18

4.01

1.1

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

168

2.08

4.00

1.1

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

5.53

3.95

1.2

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

317

1.76

3.94

1.8

1.2

—

(1761868) Lipid panel - Serum or Plasma

1753

18962

0.90

3.91

3.5

2.9

—

(3044009) aPTT.lupus sensitive (LA screen)

3.24

3.86

1.2

1.3

—

(4146454) Self-monitoring of blood glucose

101

669

1.51

3.81

3.2

2.5

—

(3000060) B lymphocytes [#/volume] in Blood

132

2.19

3.80

2.4

138.00

1534.55

e6/l

1.30

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.67

3.76

1.0

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

482

1.59

3.74

2.3

2.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

146

2.12

3.74

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

140

2.13

3.70

1.1

—

(3022689) Creatine [Moles/volume] in Urine

134

2.16

3.67

2.2

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

438

1.62

3.67

3.2

2.3

—

(1002224) Polysomnography panel

125

1748

0.71

3.67

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

6.63

3.65

1.5

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

106

721

1.47

3.55

1.2

3.41

4.23

u/ml

0.24

241

(40759836) Histone Ab [Presence] in Serum by Immunoblot

366

1.66

3.52

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

366

1.66

3.52

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

103

698

1.47

3.51

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.56

3.50

1.1

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

367

1.66

3.49

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

131

2.13

3.45

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.69

3.44

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

479

4025

1.19

3.42

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

646

1.48

3.40

1.1

118.45

115.62

0.35

583

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

455

1.58

3.40

1.0

211.96

350.59

ng/l

13.57

304

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

370

1.64

3.40

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

370

1.64

3.40

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

370

1.64

3.40

1.2

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.50

3.37

1.8

3.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

119

1650

0.71

3.35

2.4

1.7

5.18

3.60

mg/l

0.74

1184

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

457

1.57

3.34

1.0

797.31

712.83

ng/l

0.79

296

(40758047) Lysozyme [Mass/volume] in Pleural fluid

2.56

3.33

1.0

1.1

11.72

7.90

mg/l

0.63

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.49

3.33

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.49

3.33

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.49

3.33

1.3

1.2

—

(3002256) Pathology report gross observation

936

8299

1.14

3.32

1.3

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

5.69

3.32

2.3

1.8

182.50

149.00

umol/l

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.82

3.31

1.1

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

101

2.27

3.31

1.2

81.82

80.56

0.03

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.60

3.26

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

461

1.56

3.23

1.0

29.27

46.99

ng/l

9.07

303

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.43

3.17

1.1

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2209

20572

1.09

3.14

4.8

5.1

3.90

3.56

ug/l

0.22

1920

18363

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

150

1.99

3.14

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.30

3.12

1.0

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.72

3.11

2.6

2.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.41

3.08

1.0

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.24

3.08

1.9

3.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

661

1.45

3.07

1.5

1.4

20292.21

155018.30

e6/l

4.60

449

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.65

3.06

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

174

1.89

2.98

1.6

1.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

9.95

2.97

5.8

3.6

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.53

2.97

1.0

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

218

1.78

2.95

1.5

1.4

67.44

54.68

1.36

186

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

101

2.17

2.88

1.2

78.60

76.80

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

3.42

2.87

2.1

1.4

6.64

3.91

nmol/l

0.40

(3000492) Spirometry study

611

5319

1.15

2.86

1.6

1.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

4.07

2.86

1.0

219.67

297.05

nmol/l

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

460

1.52

2.84

1.8

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

674

1.42

2.80

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.55

2.76

1.8

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.53

2.75

1.1

1.0

21.00

13.05

iu/ml

—

(3050794) Legionella sp Ab [Presence] in Serum

3.06

2.74

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

433

0.50

2.73

1.3

1.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.41

2.67

1.1

1.3

97.88

103.38

ug/l

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

403

1.53

2.67

3.9

4.7

297.01

129.55

u/ml

0.42

117

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

632

1.42

2.64

1.2

1.1

3.26

4.27

u/ml

0.34

238

(3024263) Appearance of Synovial fluid

341

1.58

2.63

1.6

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.13

2.62

1.0

—

(44813793) Dust mix specific IgE antibody measurement

358

1.56

2.60

1.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.45

2.58

8.2

5.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.32

2.58

1.1

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

162

1.84

2.57

1.0

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

7.10

2.54

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

314

0.44

2.53

1.4

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

328

2747

1.20

2.52

1.7

1.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.71

2.51

1.0

1.1

6.67

10.00

u/l

0.74

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

191

1513

1.26

2.50

1.8

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

245

1.67

2.50

1.1

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.44

2.46

2.0

2.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

4.35

2.46

1.0

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.31

2.45

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.54

2.41

1.0

1.2

1.99

1.78

umol/24h

0.17

(3008536) Aspergillus sp Ab [Presence] in Serum

123

1.94

2.41

1.9

2.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

651

0.62

2.40

1.4

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

837

7531

1.12

2.38

1.4

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

6.22

2.36

1.0

1.1

—

(3019174) dRVVT (LA screen)

2.60

2.33

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.81

2.32

1.0

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

168

1.78

2.31

1.3

1.9

166.60

175.72

0.28

158

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

154

1.81

2.29

1.9

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

126

1.90

2.26

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.46

2.25

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

5.53

2.20

1.8

1.3

—

(3018291) Platelet Ab [Presence] in Serum

5.53

2.20

1.6

1.0

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.08

2.19

1.1

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.84

2.19

1.1

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

2.67

2.18

1.0

—

(3006270) Folate [Moles/volume] in Blood

599

1.38

2.15

1.4

1.2

324.79

330.08

nmol/l

0.08

486

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.26

2.14

1.0

1.4

347.22

497.01

nmol/l

—

(3000285) Sodium [Moles/volume] in Blood

108

1.94

2.11

1.6

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

109

1.92

2.06

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.97

2.06

1.2

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.89

2.05

1.4

1.1

—

(40768795) Lymph node Pathology biopsy report

648

1.35

2.03

1.3

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

123

1561

0.78

2.02

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

117

1.87

2.02

2.4

2.8

103.52

102.42

au/ml

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

949

8677

1.10

2.01

4.8

4.4

35.81

33.07

8.68

661

5653

(3025549) Creatine [Moles/time] in 24 hour Urine

2.39

2.00

1.4

1.3

—

(4212803) Bone marrow aspirate examination

2.27

1.95

1.2

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

112

1.87

1.92

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

120

1.83

1.89

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

274

1.53

1.87

1.1

1.18

1.06

ratio

0.73

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

121

1.81

1.84

1.9

1.4

109.14

108.65

ng/l

0.01

121

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1692

15905

1.07

1.83

1.7

1.6

1.36

1.30

mmol/l

1.09

1362

12911

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

192

1.61

1.73

5.7

5.6

67.17

71.30

0.31

149

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

228

0.48

1.70

1.4

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.28

1.68

1.5

1.8

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.49

1.66

1.0

1.9

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.43

1.63

1.1

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

112

1.78

1.61

17.7

7.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

209

0.48

1.59

1.6

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

158

1.64

1.58

1.5

1.7

9.88

8.89

ug/l

0.58

158

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

357

0.61

1.52

1.5

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.91

1.51

1.9

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

158

1307

1.21

1.51

1.7

1.4

346.37

196.76

pmol/l

0.73

149

1276

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.32

1.51

1.2

1.0

—

(3001556) Androgen free Index in Serum or Plasma

2.84

1.49

1.2

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

331

1.41

1.49

1.3

1.4

—

(40758292) HTLV I+II Ab panel - Serum

1.85

1.47

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

387

0.64

1.43

1.4

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.78

1.40

18.8

7.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.40

1.38

1.6

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

359

0.64

1.37

1.4

—

(3020650) Glucose [Presence] in Urine

165

1.57

1.37

2.0

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

102

817

1.24

1.36

1.3

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

358

0.64

1.36

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

358

0.64

1.36

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

142

1.61

1.35

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.13

1.32

1.9

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.12

1.31

1.5

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

293

0.61

1.30

1.6

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

389

0.66

1.29

1.5

1.3

87.67

193.47

pmol/l

3.15

389

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

152

1276

1.19

1.29

1.9

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

123

1015

1.21

1.26

1.7

1.8

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

301

0.63

1.23

1.5

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.62

1.21

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

142

0.49

1.20

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

220

1.45

1.20

1.3

1.6

3.20

7.06

ug/l

0.79

162

(3027035) Albumin [Mass/time] in 24 hour Urine

1.99

1.14

1.0

1.2

—

316.53

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

315

1.36

1.14

2.3

2.1

73.30

59.82

ug/min

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.49

1.14

1.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.49

1.14

1.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.49

1.14

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

166

1422

1.16

1.14

4.9

3.6

24.87

29.99

mg/l

1.24

106

860

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

343

1.34

1.10

2.2

1.5

0.88

0.93

g/l

0.87

343

(3005033) Fetal Nuchal fold Thickness US

291

0.65

1.09

1.5

1.4

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

487

0.73

1.07

11.3

2.9

13.84

13.25

1.72

482

(3014599) Egg white IgE Ab [Units/volume] in Serum

194

1.44

1.03

1.0

1.1

0.81

1.90

u/ml

0.39

(40768800) Prostate Pathology biopsy report

116

1360

0.85

1.03

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.26

1.02

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.79

0.96

1.1

1.0

—

6.00

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.60

0.91

2.3

2.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

166

1.44

0.91

1.0

0.36

2.30

u/ml

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.13

0.91

1.5

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

551

5858

0.93

0.91

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

278

1.32

0.88

5.6

6.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1605

16528

0.96

0.86

4.2

4.4

21.32

21.81

0.59

782

8621

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.99

0.86

1.7

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

274

0.69

0.86

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.71

0.84

1.2

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.93

0.84

1.2

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.68

0.80

25.5

7.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

205

1.36

0.80

1.1

0.63

0.94

u/ml

0.34

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

105

1.52

0.79

1.3

3.0

238.90

171.90

ng/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

744

7791

0.94

0.79

1.4

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.1

—

0.15

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.16

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.81

0.78

1.3

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.66

0.78

2.9

5.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.61

0.76

7.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.16

0.76

1.2

1.0

—

(40765096) Chromosome analysis panel by Banding

199

1.35

0.75

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.56

0.73

1.2

1.6

—

(3001729) Color of Synovial fluid

1.57

0.70

1.4

1.8

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.84

0.68

1.4

1.3

221.20

316.11

umol/24h

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

711

1.16

0.66

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

248

1.28

0.66

1.1

1.0

—

(3034426) Prothrombin time (PT)

170

1.35

0.65

1.3

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

1.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

0.12

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.60

0.0

1.0

—

7.92

—

(3036071) Salmonella sp Ab [Titer] in Serum

139

1.36

0.58

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

275

0.76

0.58

1.7

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.50

0.58

1.3

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

141

1548

0.90

0.56

1.3

—

(3008898) HLA-B27 [Presence]

132

1451

0.90

0.55

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

229

1.26

0.54

1.2

39.28

39.94

g/l

0.08

122

(3026470) Cobalt [Mass/volume] in Blood

504

1.17

0.52

1.9

3.12

3.60

ug/l

0.22

461

(3051101) Glucose [Moles/volume] in Cord blood

133

0.67

0.51

5.3

5.8

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

280

0.78

0.51

1.3

1.4

1.56

1.59

g/l

0.14

280

(3012494) Peanut IgE Ab [Units/volume] in Serum

117

1.36

0.50

1.0

1.1

0.65

9.37

u/ml

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.42

0.45

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.42

0.44

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

691

1.12

0.44

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

202

1.23

0.41

1.0

1.1

93.40

95.22

0.15

157

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

452

0.86

0.40

1.1

1.21

4.11

u/ml

2.62

211

(3025577) Chromium [Mass/volume] in Blood

493

1.13

0.37

2.1

1.9

1.74

2.36

ug/l

0.98

413

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

270

1.18

0.36

4.3

4.1

53.80

55.59

u/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.28

0.36

1.1

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.38

0.35

1.8

1.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

117

1077

1.08

0.34

4.4

3.8

45.79

45.52

u/ml

0.01

112

1039

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

107

985

1.08

0.32

2.1

1.8

174.68

207.96

pmol/l

2.02

934

(1617658) Protocol used for examination of sentinel lymph nodes

536

0.89

0.32

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

341

1.14

0.30

5.3

3.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

543

0.90

0.29

1.1

0.47

1.15

u/ml

1.51

283

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.22

0.27

1.1

—

(3003338) MCHC [Mass/volume]

5074

50727

0.99

0.26

44.4

18.9

333.86

331.60

g/l

48.49

5033

50197

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

292

1.12

0.23

1.0

1.1

8.26

10.66

iu/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

618

1.08

0.22

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

697

1.07

0.21

1.2

1.1

0.67

1.78

u/ml

2.31

375

(3003740) Influenza virus B Ag [Presence] in Specimen

622

1.07

0.19

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

155

1.16

0.18

1.1

—

(3015183) Erythrocyte sedimentation rate

204

0.88

0.17

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

243

1.11

0.16

1.0

1.2

—

(40762814) Titanium [Mass/volume] in Blood

142

1.12

0.11

2.0

2.1

4.24

3.72

ug/l

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

140

1357

1.03

0.09

1.8

1.7

53.75

43.11

nmol/l

3.22

133

1308

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.08

0.09

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.06

0.09

1.2

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

125

1.11

0.09

5.6

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

146

1.09

0.07

1.6

1.8

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

364

0.96

0.06

1.1

0.07

0.35

u/ml

—

120

(3023430) Cat dander IgE Ab [Units/volume] in Serum

412

0.97

0.05

1.1

0.96

3.63

u/ml

2.65

167

(40768793) Breast Pathology biopsy report

151

1480

1.01

0.05

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

257

1.04

0.04

1.2

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

118

1187

0.99

0.03

1.4

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

151

1.05

0.02

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

588

1.01

0.01

1.1

0.69

0.92

u/ml

0.28

271

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

331

1.02

0.01

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

610

1.01

0.00

1.1

2.01

3.98

u/ml

0.99

313

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

171

0.99

0.00

1.5

1.3

18.00

33.53

1.30

116

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

107

1.02

0.00

3.7

2.1

—

(3025130) Human papilloma virus identified in Specimen

518

1.00

0.00

1.6

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

104

0.96

0.00

1.3

1.1

3.97

9.40

u/ml

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

141

0.99

0.00

1.0

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

140

0.99

0.00

1.2

1.5

1.80

2.21

ug/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

334

1.01

0.00

1.1

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

-0.00

0.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.99

-0.00

1.2

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

2.0

—

5.29

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.50

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

7.1

—

0.21

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.97

-0.00

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.86

-0.00

1.8

2.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_HYPOOSMNAT and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_HYPOOSMNAT	1.818 [1.65, 2.01]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.155

During the follow-up period (1.1.1998 — 31.12.2019), 18945 out of 38171 females with E4_HYPOOSMNAT died.

Males

Parameter	HR [95% CI]	p-value
E4_HYPOOSMNAT	3.849 [3.34, 4.44]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 10179 out of 20213 males with E4_HYPOOSMNAT died.

Mortality risk

Mortality risk for people of age

years, who have E4_HYPOOSMNAT.

N-year risk	Females	Males
1	0.202%	0.881%
5	0.978%	4.201%
10	2.405%	10.121%
15	4.636%	19.417%
20	8.313%	30.311%

Relationships between endpoints

↥

Index endpoint: E4_HYPOOSMNAT – Hypo-osmolality and hyponatraemia

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hypo-osmolality and hyponatraemia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints